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2 Summary 
Follicular dendritic cells (FDCs) constitute an important cell type in the germinal 
center (GC) reaction. They are thought to supply GC B cells with essential survival 
signals, drive affinity maturation and control generation and maintenance of memory 
B cells. 
The exact molecular mechanisms of these processes are not well defined and 
despite their central role in the GC reaction, FDCs are probably one of the most 
poorly understood cell types of the immune system.  
Apart from their beneficial role in adaptive immunity FDCs also exert a noxious role in 
certain pathologies. It is well established that FDCs trap large amounts of HIV virions 
and thereby contribute to the pathogenesis of AIDS. Furthermore, FDCs also 
participate in prion diseases by replication and accumulation of disease-associated 
PrPSc in lymphoid organs.  
To gain deeper insights into FDC-biology by identifying FDC-specific genes and also 
to identify important factors that make FDCs such efficient prion replicators, an 
unbiased transcriptomic screen has been conducted. One interesting candidate 
found was the phosphatidylserine (PS)-binding protein Mfge8, which was further 
investigated here. 
The observation that FDCs of Mfge8-/- mice lacked FDC-M1 expression, one of the 
most specific markers used to define FDCs, but of unknown identity, let to the 
discovery that FDC-M1 and Mfge8 are identical. This discovery enables new 
methods to study FDCs. 
The role of Mfge8 in the removal of apoptotic cells is well established. It binds to PS 
on the surface of apoptotic cells, which is then recognized by integrins expressed on 
macrophages. This interaction then induces the internalization of the apoptotic cell. 
Consequently, tangible body macrophages (TBMφs) of Mfge8-/- mice exhibit a 
phagocytosis defect leading to impaired removal of apoptotic B cells from the GC. 
This was reported to result in the autoimmune disease systemic lupus erythematosus 
(SLE). However, this report claimed that Mfge8 was produced by TBMφs and not by 
FDCs.  
This view was refuted here by a detailed analysis of Mfge8 expression in the spleen 
using reciprocal bone marrow (BM) chimeras between wild-type (WT) and Mfge8-/- 
mice. In these mice Mfge8 expression was restricted to radiation resistant FDCs. 
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Radiation sensitive TBMφs failed to show any detectable Mfge8 RNA expression. 
However, Mfge8 protein was easily detectable in TBMφs when FDCs expressed 
Mfge8. This has led to a novel model of apoptotic cell removal in the GC, in which 
FDCs produce Mfge8 and opsonize apoptotic cells to target them for removal by 
TBMφs. Cell death occurs frequently in the GC, but TBMφs are a rare cell type, which 
might be limiting for apoptotic corpse removal. Thus, by supplying TBMφs with 
detailed topological information were to engulf apoptotic cells FDCs guarantee a 
rapid and efficient removal of dying cells. 
The question whether Mfge8 also contributes to prion pathogenesis was also 
addressed here. Mfge8 produced by FDCs seemed to be irrelevant for prion 
replication and accumulation in lymphoid organs. In contrast to this, Mfge8-/- mice 
showed a drastically accelerated prion pathogenesis after intracerebral inoculation, 
where disease progression is independent of prion replication in lymphoid organs. 
This acceleration was associated with higher levels of PrPSc in the brain. However, 
this phenotype was dependent on the genetic background. Whether Mfge8-
deficiency leads to impaired removal of prions from the brain and why this occurs 
only in a specific genetic background will be addressed in the future. 
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3 Zusammenfassung 
Follikuläre dendritische Zellen (FDCs) stellen einen wichtigen Zelltyp in der 
Keimzentrumsreaktion dar. Man nimmt an, dass sie B Zellen im Keimzentrum mit 
wichtigen Überlebenssignalen versorgen, die Affinitätsreifung von B Zellen  
kontrollieren, sowie die Entstehung und Erhaltung von B-Gedächtniszellen 
regulieren. 
Die genauen molekularen Mechanismen dieser Prozesse sind nicht genau bekannt, 
und trotz ihrer wichtigen Rolle in der Keimzentrumsreaktion, sind FDCs einer der 
wohl am schlechtesten verstandenen Zelltypen des Immunsystems. 
Ausser ihrer nützlichen Rolle in der adaptiven Immunabwehr, spielen FDCs auch 
eine schädliche Rolle in bestimmten Krankheiten. Es ist bekannt, dass FDCs grosse 
Mengen an HIV-Virionen binden und dadurch zur AIDS-Pathogenese beitragen. 
Desweiteren sind FDCs auch an Prionenerkrankungen beteiligt, indem sie das 
pathologische PrP-Konformer PrPPSc in lymphatischen Organen vermehren und 
anreichern.  
Um ein genaueres Verständnis der FDC-Biologie duch die Identifikation FDC-
spezifischer Gene zu bekommen und um wichtige Faktoren für die Prionen-
replikation, zu identifizieren, wurde eine unvoreingenommene Analyse des FDC-
Transkriptoms durchgeführt. Ein interessanter Kandidat, der dabei gefunden wurde, 
war das Phosphatidlyserin (PS)-bindende Protein Mfge8, was hier genauer 
untersucht wurde. 
Die Entdeckung, dass FDCs von Mfge8-/- Mäuse kein FDC-M1 produzieren, das 
einer der spezifischten FDC-Markern darstellt, aber dessen Identität bis dahin 
unbekannt war, hat zur Identifikation von FDC-M1 als Mfge8 geführt. Diese 
Entdeckung wird neue Methoden der Erforschung von FDCs ermöglichen. 
Es ist bekannt, dass Mfge8 an der Beseitigung von apoptotischen Zellen beteiligt ist. 
Mfge8 bindet an PS, dass sich an der Oberfläche von apoptotischen Zellen befindet, 
was dann wiederum von Integrinen, die auf Makrophagen exprimiert werden erkannt 
wird. Diese Interaktion induziert die Internalisierung der apoptotischen Zelle durch 
den Makrophagen. Folglich zeigen Tingible-Body Makrophagen (TBMφs) von Mfge8-/- 
Mäusen einen Phagozytose-Defekt, was eine gestörte Beseitigung von 
apoptotischen Zellen zur Folge hat und schliesslich zu der systemischen 
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Autoimmunerkrankung Lupus Erythematodes (SLE) führt. In dieser Studie wurde 
allerdings berichtet, dass Mfge8 von TBMφs und nicht von FDCs produziert wird. 
Diese Ansicht konnte hier durch eine detaillierte Analyse der Mfge8-Expression in der 
Milz von Knochenmarkschimären zwischen Wildtyp und Mfge8-/- Mäusen widerlegt 
werden. Mfge8-Expression konnte in diesen Chimären nur in den 
strahlungsresistenten FDCs gefunden werden. In strahlungssensitiven TBMφs konnte 
dagegen keine Mfge8-Expression nachgewiesen werden. Das Mfge8-Protein war 
allerdings in TBMφs präsent, wenn FDCs Mfge8 exprimierten. Diese Entdeckung 
führte zu einer neuen Hypothese zur Beseitigung apoptotischer Zellen im 
Keinzentrum. Diese Hypothese besagt, dass Mfge8, das von FDCs produziert wird, 
apoptotische Zellen opsonisiert um sie für die Beseitigung durch TBMφs zu 
markieren. Im Keimzentrum ist Apoptose häufig, TBMφs sind dagegen aber ein 
seltener Zelltyp, was auf die Beseitigung apoptotischer Zellen limitierend wirken 
könnte. Um trotzdem eine effiziente und schnelle Beseitigung der apoptotischen 
Zellen zu gewährleisten, teilen FDCs den TBMφs genaue topologische Informationen 
zur Lage von apoptotische Zellen, durch die Produktion von Mfge8, mit. 
Auch die Frage, ob Mfge8 zur Prionen-Pathogenese beiträgt wurde hier behandelt. 
Dabei wurden keine Hinweise darauf gefunden, dass Mfge8, das von FDCs 
produziert wird, die Prionenreplikation oder -anreicherung in lymphatischen Organen 
beeinflusst. Im Gegensatz dazu war die Prionen-Pathogenese in Mfge8-/- Mäusen, 
die intracerebral inokuliert wurden und damit unabhängig von Prionenreplikation in 
lymphatischen Organen war, drastisch beschleunigt. Diese Beschleunigung war mit 
erhöhten Mengen von PrPSc im Gehirn verbunden. Allerdings war das Auftreten 
dieses Phänotyps abhänging vom genetischen Hintergrund der untersuchten Mäuse. 
Ob das Fehlen der Mfge8-Expression zu einem gestörten Abbau von Prionen im 
Gehirn führt und warum die beschleunigte Pathogenese nur in einem bestimmten 
genetischen Hintergrung auftritt, ist Gegenstand zukünftiger Untersuchungen. 
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4 Abbreviations 
AID activation-induced cytidine deaminase 
ALZ apical light zone 
ANA anti-nuclear antibody 
AP alkaline phosphatase 
APC antigen-presenting cell 
BALT bronchial associated lymphoid tissue 
BCR B-cell receptor 
BLC B-lymphocyte chemoattractant 
BM bone marrow 
BSA bovine serum albumin 
BSE bovine spongiform encephalopathy 
BLZ basal light zone 
CD cluster of differentiation 
cDNA complementary DNA 
CJD Creutzfeld-Jakob disease 
CNS central nervous system 
CWD chronic wasting disease 
DC dendritic cell 
DIG digoxygenin 
dsDNA double-strand DNA 
DZ dark zone 
ELISA enzyme-linked immunosorbent assay 
EM electron microscopy 
FCS fetal calf serum 
FcR Fc receptor 
FDC follicular dendritic cell 
FRC fibroblastic precursor cell 
GALT gut associated lymphoid tissue 
GC germinal center 
GFAP glial fibrillary acidic protein 
GSS Gerstmann-Sträussler-Scheinker syndrome 
H&E hematoxylin and eosin 
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HEV high endothelial venules 
HRP horseradish peroxidase  
i.c. intracerebral 
i.p. intraperitoneal 
IC immune complex 
ICAM intercellular adhesion molecule 
IF immunofluorescence 
IFN interferon 
Ig immunoglobuline 
IHC immunohistochemistry 
IL interleukin 
ISH in situ hybridization 
LN lymph node 
LPS lipopolysaccharide 
LT lymphotoxin 
LTβR LTβ receptor 
Mφ macrophage 
MadCAM mucosal addressin cell adhesion molecule 
Mfge8 Milk fat globule-EGF factor 8 protein 
MZ mantle zone 
NK cell natural killer cell 
OVA ovalbumin 
PALS periarteriolar lymphoid sheath 
PAS periodic acid-Schiff 
PBS phosphate buffered saline 
PK proteinase K 
PP Peyer´s patch 
PrPC cellular isoform of the prion protein 
PrPSc pathological isoform of the prion protein 
PS phosphatidylserine 
qPCR quantitative PCR 
RT reverse transcriptase 
RU response unit 
SD standard deviation 
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SLE systemic lupus erythematosus 
SPR surface plasmon resonance 
TBMφ tangible body macrophage 
TBS tris-buffered saline 
TCR T-cell receptor 
TD T cell dependent 
TNF tumor necrosis factor 
TSE transmissible spongiform encephalopathy 
TUNEL terminal deoxynucleotidyl transferase mediated dUTP nick end 
labeling 
VCAM vascular cell adhesion molecule 
WT wild-type 
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5 Introduction 
 
5.1 Secondary lymphoid organs 
The immune system is divided into several functionally different compartments. The 
two major compartments are the primary and secondary lymphoid organs. In mice 
and humans primary lymphoid organs, the sites where lymphocyte development and 
maturation take place, comprise the bone marrow (BM) and the thymus, The BM is 
the site of B-cell maturation. After successful rearrangement of the B-cell receptor 
(BCR) genes, B cells expressing a functional BCR on their surface leave the BM and 
home to the periphery (Benschop and Cambier, 1999). The thymus, on the other 
hand, is the main site for T-cell development. After rearrangement of the T-cell 
receptor (TCR) genes, T cells undergo positive and negative selection, which 
ensures tolerance to host-specific antigens and helps preventing autoimmunity. 
Thereafter, T cells expressing a functional non-self reacting TCR are released into 
the periphery (Strasser, 1995). 
The secondary lymphoid organs include the spleen, lymph nodes (LN) and various 
lymphoid tissues that are located in mucosal surfaces, such as gut-associated 
lymphoid tissue (GALT), bronchial-associated lymphoid tissue (BALT), tonsils and 
Peyer´s Patches (PPs). Their function is to monitor the lymph and the blood for the 
presence of pathogens. The location of these lymphoid organs - mucosal surfaces 
and skin - is optimized in such a way that allows accessory cells of the immune 
system to rapidly encounter and trap pathogens at their main entry sites and thus 
elicit an adaptive immune response. In other organs, where lymphoid structures are 
typically absent, ectopic tertiary lymphoid follicles can form upon chronic 
inflammations (Fu and Chaplin, 1999).  
 
5.1.1 Structural organization of secondary lymphoid organs  
Although secondary lymphoid organs share several common features, they differ in 
their microarchitecture and organization, as will be described here for LNs and 
spleen.  
Essentially, LNs are supplied by two vascular systems: the lymph vasculature which 
delivers antigen and antigen-presenting cells (APCs) to the LN, and the blood 
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vasculature which transports lymphocytes to the LN. LNs are surrounded by the 
marginal sinus which is connected to the afferent lymphatic vessels that empty into 
the subcapsular sinus. Lymph leaves the LN via efferent lymphatic vessels in the 
medullary region. LNs are subdivided into three regions: cortex, paracortex and 
medulla. The cortex comprises the outermost layer of the LN and contains the 
primary lymphoid follicles. The paracortex lying just beneath the cortex consists 
mainly of T cells and APCs. High endothelial venules (HEVs) where lymphocytes 
from the blood enter the LN are also located in the paracortex. The medulla, the 
innermost region of the LN, contains medullary cords with plasma and T cells. The 
medullary cords are separated by vessel-like structures called medullary sinuses, 
which contain macrophages and plasma cells (Witmer and Steinman, 1984, 
Castenholz, 1990)  (Figure 1.1). 
 
Figure 1.1 Organization of a 
lymph node. 
Afferent lymphatics transport 
pathogens and APCs to the LN. 
Lymphocytes enter the LN via the 
blood stream and leave it again via 
efferent lymphatic vessels. 
The cortex of the LN contains 
primary and secondary follicles. 
The paracortex, which is located 
deeper in the LN consists mainly of 
T cells and dendritic cells. The 
innermost area, the medulla mainly 
contains macrophages and plasma 
cells. 
Adapted from Janeway et al., 
2001. 
The spleen, on the contrary, is subdivided into red and white pulp, the majority 
comprising red pulp, which mainly contains erythrocytes targeted for destruction. 
Furthermore, it also includes a reticular network of stromal cells, macrophages and 
plasma cells. The lymphocytes in the spleen are mainly located in the white pulp, the 
site of activation and maturation of B and T cells during an immune response. 
The white pulp is surrounded by the marginal zone containing cells that are optimized 
for antigen trapping such as the marginal zone B cells and specialized macrophages 
that are thought to regulate the delivery of antigen to the white pulp (Groeneveld et 
al., 1986). The inner region of the white pulp is divided into B cell zone and T cell 
zone or periarteriolar lymphoid sheath (PALS) surrounding the central arteriol.  
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In contrast to the LNs the spleen is not supplied by afferent lymphatics. Blood-borne 
antigen is delivered to the spleen through the splenic artery which empties into the 
marginal zone, where the antigen is efficiently trapped (Witmer and Steinman, 1984, 
Timens, 1991) and further transported into the follicle. 
The structural organization of the mucosa-associated lymphoid tissues (including 
PPs, BALT and GALT) compares to the LNs, in contrast to the antigen delivery 
pathway: antigen is transported through the mucosal epithelium rather than via 
afferent lymphatics. Specialized cells, called M cells have been shown to transport 
pathogens from the lumen to the mucosa (Neutra and Kraehenbuhl, 1992). On the 
abluminal side, lymphocytes re-enter the blood via efferent lymphatic vessels. 
 
Figure 1.2 Organization of a splenic secondary follicle with its major cell types. 
The outer-most layer separating the white pulp follicles from the red pulp is the marginal zone, 
which contains CD21high marginal zone B cells, MOMA1+ metallophilic macrophages and ER-
TR9+ marginal zone macrophages. GCs arise in the B cell zone of the follicle. Apart from B cells, 
this area is populated by GC T cells, follicular dendritic cells (FDCs) and tingible body 
macrophages (TBMφs). The T cell zone mainly contains T cells and APCs like dendritic cells 
(DCs). 
5.1.2 Germinal centers 
Germinal centers (GC) arise in primary follicles. Follicles that contain a GC are called 
secondary follicles. GCs are divided into different compartments referred to as mantle 
zone (MZ), outer zone (OZ), apical light zone (ALZ), basal light zone (BLZ) and dark 
zone (DZ). The MZ contains mainly recirculating B cells, while the OZ comprises a 
very heterogenous population of different lymphocytes. In the ALZ small centrocytes 
are predominantly found, and large centrocytes reside mainly in the BLZ and 
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centroblasts in the DZ (MacLennan, 1994) (Figure 1.3). GC generation occurs in 
response to a T-cell dependent (TD) antigen and is established by very few founder 
B cells. The limiting factor for the GC generation in a primary response to TD antigen 
is T cell help. Because an activated antigen-specific T cell has to get in contact with a 
B cell carrying the cognate BCR, it can take up to several days from the initial 
infection with TD antigen to the first activation of B cells (Liu et al., 1991). Initially, B 
cells interact with active CD4+ T-cells outside the GC in the T cell zone (Gray, 1988). 
These B cells then migrate into the GC where they proliferate in the dark zone of the 
GC (clonal expansion). These highly proliferating B cells, known as centroblasts, 
downregulate their expression of surface immunoglobuline (Ig), especially IgD. The 
progeny of these centroblasts are the centrocytes, which upregulate their surface Ig-
expression. They do not proliferate and are located in the light zone of the GC 
(MacLennan, 1994). The light zone also contains the follicular dendritic cells (FDCs), 
which display antigen in its native form as immune-complexes (ICs) bound to 
complement- and Fc-receptors on their surface. The survival of the centrocytes is 
dependent on their ability to react with the antigen presented by FDCs. Only 
previously activated B cells have the ability to react with antigen displayed by FDCs 
(Burton et al., 1993). The centrocytes are also suggested to take up the antigen from 
FDCs, process it and present it to T cells in order to get T cell help and to start 
another round of clonal expansion. This interaction is crucial for somatic 
hypermutation, a process in which B cells in the GC undergo a site-directed 
hypermutation that introduces point mutations in their Ig-variable region genes. This 
process is dependent on a protein called activation-induced cytidine deaminase 
(AID), which also regulates class-switching of Igs (Muramatsu et al., 2000). To 
Figure 1.3 Scheme of a GC. 
The GC is subdivided into five different compartments. The MZ, 
which contains mainly recirculating B cells, the OZ with a very 
heterogenous lymphocyte population, the ALZ containing small 
centrocytes, the BLZ with large centrocytes and the DZ, which 
contains centroblasts. 
Adapted from Imai and Yamakawa, 1996.
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prevent generation of self-reactive autoimmune antibodies by this process, B cells 
have to continuously compete not only for the binding to ICs presented by the FDCs, 
but also for T cell help. This process leads to generation only of B cells bearing high-
affinity receptors for the cognate antigen. Cells that fail to express a high-affinity 
receptor, either because affinity-maturation resulted in a non-functional B cell 
receptor (BCR) or their receptor displayed lower antigen affinity, undergo apoptosis, 
when they fail to interact with FDCs or T cells and therefore to receive essential 
survival signals. Not all of these survival signals have been identified so far, but one 
of them is signaling through the BCR. Also binding of T cell derived CD40L which is 
the ligand of CD40, a member of the TNF-receptor superfamily expressed by B cell 
has been shown to play a central role (Guzman-Rojas et al., 2002) in GC B cell 
survival. The high number of apoptotic B cells is removed by a specialized highly 
phagocytic macrophage population called tingible body macrophages (TBMφ) 
(Swartzendruber and Congdon, 1963). The surviving cells differentiate either into 
memory B cells or plasmablasts that leave the follicle and migrate to sites of high 
antibody production, like the red pulp of the spleen or the medullary cords of LNs 
where they differentiate into non-dividing plasma cells (MacLennan, 1994). Plasma 
cells migrate further to the BM, where they can sustain for long periods. The Ig 
isotype produced by plasma cells varies and is dependent on the origin of the plasma 
cell. While plasma cells that originate from the spleen or peripheral LNs mainly 
produce IgG, plasma cells originating from the PPs or mesenteric LNs produce 
mainly IgA (Kraal et al., 1986, Weinstein and Cebra, 1991, Weinstein et al., 1991). 
The class-switch occurs already in the GC, before centrocytes are committed to 
become a plasmablast or memory B cell. The switch-decision is controlled by several 
cytokines, for example IL-4 promotes the switch to IgE and IL-5 is important for IgA 
production. In contrats, IL-1 controls the switch to IgG1 and IgE. IFN-γ is important for 
the switch to IgG3 and IgG2a while TGF-β is needed for the switch to IgG2b and IgA 
(Lorenz and Radbruch, 1996).  
Memory B cells can be found in follicles long after the initial immune response, when 
the GC is not present any more. Memory B cells proliferate in response to native 
antigen displayed by FDCs. They can give rise to plasma cells and memory B cells 
without inducing a GC (Liu et al., 1991). 
 
 
 15
Introduction 
_____________________________________________________________________________________________________ 
5.2 Follicular Dendritic Cells 
5.2.1 Origin and Development  
Follicular dendritic cells (FDCs) are found in peripheral lymphoid tissues where they 
reside in primary B cell follicles and GCs (Chen et al., 1978). Until today the cellular 
origin of FDCs remains enigmatic although most evidence points to a mesenchymal 
and not to a hematopoietic origin of FDCs. First of all, during postnatal development 
several transitional states between FDCs and fibroblastic precursor cells (FRC) have 
been described (Heusermann et al., 1980, Dijkstra et al., 1982, Dijkstra et al., 1984, 
Imai et al., 1986). Furthermore, FDCs share many morphological and phenotypical 
features with fibroblasts and stromal cells (Lindhout and de Groot, 1995, Bofill et al., 
2000, Lee and Choe, 2003). More support for a stromal origin comes from BM-
reconstitution experiments, in which after BM-transfer following lethal irradiation 
FDCs where always shown to be of host origin (Humphrey et al., 1984). However, in 
one study where mice homozygous for the severe combined immunodeficiency 
(prkdcscid) mutation that lack FDCs were reconstituted with rat BM or with BM from 
mice expressing a lacZ transgene, FDCs of donor genotype were found (Kapasi et 
al., 1998). This experiment does not exclude a stromal origin, since mesenchymal 
progenitor cells presumably originating from BM can circulate in the blood 
(Campagnoli et al., 2001, Roufosse et al., 2004). The study of Imazeki et al, in which 
genetically marked spleen slices were grafted into mice, strongly supports a local 
tissue origin of FDCs. When host and donor spleens were analyzed six months after 
the engraftment, FDCs in host spleens were of host phenotype, whereas FDCs in 
grafted spleens were of donor phenotype (Imazeki et al., 1992). These results 
indicate that once the FDC-population is established, it is not replaced and remains 
stable for months, even after irradiation with lethal doses. Only if mature FDCs are 
absent, BM-derived cells can populate the FDC-compartment.  
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It is well established that the maturation of FDCs requires signaling pathways of the 
TNF superfamily (Figure 1.4). Analysis of knockout mice deficient for distinct 
members of the TNF superfamily clarified the importance of these members in FDC-
maturation (Table 1.1). The most important factors identified are the lymphotoxin β 
receptor (LTβR) and the tumor necrosis factor receptor 1 (TNFR1) and their 
membrane bound heterotrimeric ligands LTα1/LTβ2 as well as the soluble ligands 
LTα3 and TNF (De Togni et al., 1994, Rennert et al., 1996, Rennert et al., 1997, Koni 
and Flavell, 1998, Fu and Chaplin, 1999). Expression of LTβR and TNFR1 by stromal 
cells is required for FDC-maturation, while the source of LT and TNF is hematopoietic 
(Ware et al., 1995). B cells are particularly important for FDC-maturation as source of 
membrane bound LTα1/LTβ2 (Figure 1.4). Consequently, mice that lack B cells also 
lack mature FDCs. T cells are also a source of secreted LT and TNF, but are 
dispensable for FDC-maturation, as was shown by BM-reconstitution of SCID mice. If 
SCID mice were reconstituted with T cells alone, no FDC-maturation took place, 
whereas after transfer of B cells only, generation of FDCs was restored (Kapasi et al., 
1993). Signaling via LTβR and TNFR is not only involved in FDC-maturation but also 
in lymphoid organogenesis. Ltβr-/-  as well as Ltα-/- mice not only lack FDCs, but also 
all LNs and PPs and are characterized with disrupted splenic microarchitecture. This 
is also the case for Ltβ-/- mutants, however, mesenteric LNs can be found in these 
mice. Peripheral LNs but no PPs are observed in Tnf-/- and Tnfr1-/- mice and their 
Figure 1.4 LT-signaling in FDC-
maturation. 
The most important source of lymphotoxins 
needed for FDC-maturation is B cells. They 
produce the membrane bound LTα1β2 
heterotrimer which signals through the 
LTβR. B cells also produce the membrane 
bound homotrimer LTα3, which can be 
cleaved to its soluble form sLTα3. Both 
membrane-bound and soluble LTα3 signal 
through the TNFR. 
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spleens are more organized, in spite of a disrupted marginal zone. The latter contains 
cells that express CD21 and FDC-M2, which might resemble immature FDCs that are 
trapped there (Pasparakis et al., 2000)(Table 1.1). While signaling via the LT-LTβR 
axis is crucial for development and homeostasis of lymphoid tissue, the TNF-TNFR1 
signaling axis has its main function in promoting inflammatory responses (Ware et al., 
1995). 
 
Table 1.1 Deletions of LT-signaling components and their consequences for lymphoid 
organogensis. 
5.2.2 Morphological and phenotypic characterization of FDCs 
FDCs are a very heterogenous cell type in regard to their ultrastructural morphology. 
Imai and Yamakawa presented a detailed morphological study of FDCs based on 
electron microscopical (EM) analyses (Imai and Yamakawa, 1996). They compared 
FDCs in relation to their localization in different areas of the GC. The mantle zone 
(MZ) contains IgM+IgD+ small resting B cells and some intermingled FDCs. The 
FDCs connect to each other via desmosome-like junctions and only few FDC-
lymphocyte clusters, with lymphocytes encircled by smooth and slender extensions of 
the FDCs are present. These FDCs lack long branching cytoplasmic processes and 
do not form labyrinth-like structures. 
The outer zone (OZ) contains a heterogenous cell population, including centrocytes, 
plasma cells and T cells, among which the FDC network is rather loose. The FDCs 
lack FcγRII (CD23) expression, but are ultrastructurally similar to FDCs in the MZ. 
The dark zone (DZ) containing activated B cells and some TBMφs represents the site 
of centroblast proliferation. The distribution of the FDC network is expanded, but 
loose. Also in this area of the GC cytoplasmic extensions are not well developed and 
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labyrinth-like structures are absent. No FDC-lymphocyte clusters are formed, 
although some centroblasts are loosely encircled. 
In the basal light zone (BLZ) many apoptotic cells along with many centrocytes and 
TBMφs can be detected. The FDCs express complement receptor 2 (CD21) and 
intercellular adhesion molecule 1 (ICAM-1), but no CD23. They are well-organized 
and show characteristic labyrinth-like structures. The prominent cytoplasmic 
extensions form tight clusters with centrocytes, suggesting an involvement of FDCs in 
the selection of centrocytes that have undergone successful somatic hypermuation. 
Also the apical light zone (ALZ) contains centrocytes and some apoptotic bodies. The 
FDCs are very similar to those in the BLZ: high CD21 expression and presence of 
CD23 and ICAM-1. Here they form a very dense meshwork with their cytoplasmic 
extensions. The ALZ is the site where centrocytes differentiate into plasmablasts or 
memory B cells and it is believed that FDCs play a central role in this decision.  
Figure 1.5 Iccosome-bearing FDC. 
Scanning electron micrograph illustrating an isolated FDC bearing iccosomes. FDCs were isolated 
from popliteal LNs 24h after passive immunization into the footpad. Magnification 2.500x.  
From Szakal et al., 1985.  
In 1985, Szakal et al. described FDCs with beaded dendrites (Szakal et al., 1985). 
Since these beads were then shown to contain immune-complexes, they were 
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termed iccosomes (immune-complex coated bodies). Iccosomes are arranged 
periodically on the dendrites and believed to facilitate the interaction of ICs with B 
cells. 
Iccosome-bearing FDCs can only be found early in GC development (Szakal et al., 
1989). The edema around day three of GC development might facilitate iccosome 
dispersion. The free iccosomes are taken up by B cells via endocytosis. By day five 
most iccosomes are gone, but the majority of B cells contain endocytosed ICs. 
Therefore, it seems that iccosomes are important for Ag-presentation to GC B cells, 
which in turn endocytose and degrade the Ag and potentially present it to T cells in a 
processed form (Kosco et al., 1988b, Szakal et al., 1988). 
 Apart from ultrastructural analysis, a useful tool to characterize FDCs is the 
expression analysis of certain surface antigens, although none of these antigens is 
exclusively expressed by FDCs. Most surface antigens can be grouped in few 
functional categories such as cell adhesion molecules (ICAM-1, VCAM-1 or 
MadCAM-1), complement and complement receptors C1q, C4 (FDC-M2), CR1 
(CD35), CR2 (CD21), CR3 (CD11b), Fc-receptors FcεRII (CD23), FCγRII (CD32), 
and cytokine receptors (LTβR, TNFR1). Another very useful marker is FDC-M1, 
whose identity is currently unknown. Expression so far has only been shown in FDCs 
and TBMφs. The anti-FDC-M1 antibody (4C11) was developed by immunizing rats 
with enriched murine FDC fractions (Kosco et al., 1992). The obtained antibodies 
were screened by immunohistochemistry for binding to FDCs. Another antibody 
obtained by this method recognized FDCs and was termed FDC-M2. The antigen of 
this antibody was later identified as complement C4. In the study presented here, the 
antigen recognized by the anti-FDC-M1 antibody was identified and is described in 
chapter 6.1. 
 
5.2.3 Functions of FDCs 
As mentioned above, FDCs play a central role in the GC reaction. One of their most 
important features is the trapping of native antigen in form of ICs (Tew et al., 1982). 
However, it is still not entirely clear how ICs reach the FDCs and which cell types are 
involved in this transport. It is known that most antigen that arrives in the LNs is 
degraded by medullary macrophages, while only small amounts arrive in the follicle 
where they are displayed by FDCs (Fossum, 1980, Szakal et al., 1983). Further, ICs 
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are known to be transported actively to the follicle and not to travel freely (Gretz et 
al., 2000). It has been shown that subcapsular sinus (SCS) macrophages are able to 
capture ICs without degrading them. Whether these macrophages also deliver the 
antigen to the FDCs remains controversial. A recent study has shown by two-photon 
microscopy that B cells can take over ICs from macrophages and then migrate with it 
to FDCs, where they transfer the ICs onto the FDCs (Phan et al., 2007). The authors 
also demonstrated that this process is dependent on the expression of complement 
receptor CD21 by B cells, via which ICs are bound. They further suggest that the 
higher expression of CD21 by FDCs is needed to successfully compete with the IC-
transporting B cells for the binding to ICs. Once the IC is bound by an FDC, it will be 
retained for very long periods. Trapping of ICs not only occurs via complement 
receptors, but also via Fc-receptors like CD23 and CD32. The retention of ICs is 
thought to drive B cell proliferation and selection of B cells bearing high affinity BCRs. 
B cells in the GC are prone to undergo apoptosis and it is believed that FDCs supply 
B cells with survival signals as long as the B cell is able to bind to ICs displayed by 
FDCs. This hypothesis is supported by a variety of in vitro experiments. When GC B 
cells are cultured alone, they rapidly undergo apoptosis. However, when FDCs are 
added to the cultures together with T cells, FDCs form clusters with B cells and 
promote their stimulation up to 20-fold (Burton et al., 1993). This effect can be further 
increased by adding specific antigen (Kosco et al., 1992). Although the signals 
provided by FDCs that prevent the death of GC B cells are still unknown, it has 
become clear that FDCs inhibit apoptosis by inducing high levels of the cellular form 
of FAS-associated death-domain-like IL-1 converting enzyme inhibitory protein 
(cFLIP) in B cells (van Eijk et al., 2001). 
Also T cell help is important for GC B cells’ survival. If T cells are depleted from the 
co-culture system, the cluster-formation and B-cell proliferation are drastically 
inhibited. Therefore, FDCs and T cells promote the survival of GC B cells 
synergistically. To assure T cell help, it is thought that B cells take up the iccosomes 
that are shed by the FDCs, process the antigen and display it to T cells (Burton et al., 
1991). 
5.2.4 Adhesion molecules expressed by FDCs 
Expression of adhesion molecules is crucial for the FDC-GC B cell interaction and 
cluster formation. Lymphoid cells can be entirely ensheathed by FDC processes, 
which also becomes apparent when primary FDC cultures are prepared. Enriched 
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FDC preparations are always obtained as FDC clusters. If fresh lymphocytes are 
added to cultured FDCs that have lost their lymphocytes, they readily form new 
clusters (Tsunoda et al., 1992). Several adhesion molecules have been identified on 
FDCs and are proposed to play a central role in the FDC-lymphocyte interaction. 
Among these are intercellular adhesion molecule 1 (ICAM-1) and vascular adhesion 
molecule 1 (VCAM-1) on FDCs and their ligands leukocyte function-antigen-1 (LFA-
1) and very late activation antigen 4 (VLA-4) on B cells (Koopman et al., 1991, Kosco 
et al., 1992, Ree et al., 1993, Tanaka et al., 1994). Indeed, when either the ligands or 
the receptors were blocked by antibodies, cluster formation in vitro was severely 
reduced (Koopman et al., 1991). Another adhesion molecule proposed to be 
important in the clustering between B cells and FDCs was mucosal addressin cell 
adhesion molecule 1 (MadCAM). If MadCAM was blocked by antibodies, lymphocyte 
adherence to FDCs in frozen section was impaired (Szabo et al., 1997).  
Expression of both fibronection and laminin receptors on FDCs was detected by 
immunohistochemistry. These factors are needed to bind to extracellular matrices 
and to reticulin and laminin fibers, respectively (Ogata et al., 1996). Interactions 
between the cytoplasmic extensions of FDCs and fibres may be crucial to build up 
the three-dimensional framework in the lymphoid follicle (Imai and Yamakawa, 1996). 
 
5.2.5 Chemotactic attraction of lymphocytes by FDCs  
The discovery that FDCs express B-lymphocyte chemoattractant (BLC, CXCL13), a 
chemokine that binds to the chemokine receptor CXCR5 and therefore attracts 
CXCR5 expressing cells, lead to the view that FDCs play a central role in attracting B 
and T cells that are involved in the GC reaction. BLC expression is found in primary 
and secondary lymphoid follicles in LNs, spleen and PPs. In the spleen BLC is also 
expressed in cells lining the follicular sinus (Cyster, 1999, Ngo et al., 1999). Its target 
molecule CXCR5 is expressed by all mature B cells and in vitro studies have shown 
that they all respond to BLC (Forster et al., 1994, Cyster, 1999). However, in vivo 
only a subset of B cells migrates to BLC-positive areas, indicating that additional 
factors are involved in B cell positioning (Forster et al., 1994, Ansel et al., 1999). 
CXCR5 expression was also found in memory and some activated T cells. Activation 
of CD4+ T cells leads to strong CXCR5 upregulation in vivo suggesting that BLC also 
promotes the migration of T cells into the follicle. Consistent with the notion that 
production of BLC by FDCs strongly regulates GC organization is the phenotype of 
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mice deficient for BLC or CXCR5: disorganized GC with B cell accumulation around 
the central arteriol (Ansel et al., 2000). 
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5.3 Tingible body macrophages 
TBMφs are defined as a subset of mononuclear macrophages, that are highly 
phagocytic and reside in GCs of secondary lymphoid tissues. They were first 
described by Flemming in 1885 (Flemming, 1885). They contain many phagocytosed 
apoptotic cells in various stages of degradation, so called tingible bodies. These 
tingible bodies have been shown, mainly by EM studies, to originate primarily from 
phagocytosed lymphocytes. TBMφs can become very large and their size ranges 
typically between 20-30 μm (Swartzendruber and Congdon, 1963).  Histologically 
TBMφs can be best identified by their localization in the GC and by their expression 
of FDC-M1 and typical macrophage-markers like MOMA-2 (Kraal et al., 1987), Mac-2 
(Smith et al., 1991) and CD68 (macrosialin) and by their lack of F4/80 expression 
(Rabinowitz and Gordon, 1991), although one report claimed that some TBMφs 
express F4/80 under certain conditions. The same study reported that they express 
Thy-1 in a cell cycle dependent manner (Smith et al., 1988).  
The kinetics of TBMφ appearance in the developing GC was investigated by Smith et 
al. This study showed that the increase in TBMφ-number was proportional to the 
increase of the GC-size, while the TBMφ : B cell ratio remained relatively constant at 
1:350 – 1:400. It has been proposed that TBMφs are involved in the initiation of GCs 
(Kamperdijk et al., 1978), but the fact that TBMφs are not found in GCs before day 
three after antigen challenge and that GCs in old mice can develop without TBMφs 
strongly contradicts this notion. When the GCs start to decline, the number of TBMφs 
starts to reduce drastically. Therefore it is believed that TBMφs are not resident 
macrophages of the spleen, but are recruited to the follicle upon GC generation, 
which is also supported by the finding that no macrophages with TBMφ-
chararcteristics can be found in primary follicles (Smith et al., 1991) . 
Apart from their scavenging function, it has been proposed that TBMφs are involved 
in the regulation of GC reactions (Smith et al., 1998). The fact that some TBMφs 
contain endocytosed iccosomes (Szakal et al., 1988) and express MHC class II 
raises the possibility that they present FDC-derived antigen to T cells (Kosco et al., 
1988a). However, a study by Smith et al. investigating TBMφs enriched cultures for 
their ability to present antigen to T cells revealed that TBMφs are poor antigen-
presenters, but lead to suppression of IL-2 production by T cells. This suppression 
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was mediated by prostaglandins, lipids with a immuno-modulatory function. These 
results indicate that TBMφs are involved in the downregulation of GC reactions by 
suppressing IL-2 production in T cells (Smith et al., 1998). 
Figure 1.6 Tingible body macrophage. 
Electron micrograph showing a TBMφ (dotted line) with several engulfed apoptotic lymphocytes 
in different degradation stages (arrows). 
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5.4 Milk-fat globule epidermal growth factor 8 (Mfge8)  
Mfge8 (also known as lactadherin) is a secreted glycoprotein that is involved in the 
clearance of apoptotic cells. It has a signal sequence, two epidermal growth factor 
(EGF) domains, a proline/threonine (PT)-rich domain and two factor-VIII-homologous 
domains, termed C1 and C2 (Figure 1.7).  
 
 
Figure 1.7 Functional domains of the Mfge8 protein. 
Originally Mfge8 has been found in milk fat globules that carry fat secreted from 
mammary epithelial cells into the lumen during lactation (Patton and Keenan, 1975). 
In the mammary gland Mfge8 is produced by mammary epithelial cells, where it is 
needed to remove dying cells during involution of the mammary gland (Hanayama 
and Nagata, 2005). 
More recently Mfge8 was found to be expressed by immature dendritic cells, 
thioglycollate elicited peritoneal macrophages (Hanayama et al., 2002) and also 
expression by TBMφs was reported (Hanayama et al., 2004b).  
Mfge8 is able to bind apoptotic cells by recognition of phosphatidylserine (PS) which 
is displayed on the surface of apoptotic cells. PS is a component of the plasma 
membrane and is kept on the intracellular side in a healthy cell by an ATP-dependent 
aminophospholipid translocase (Balasubramanian and Schroit, 2003). During 
apoptosis PS becomes rapidly exposed on the outer side of the cell membrane. The 
interaction of Mfge8 with PS is mediated via a RGD (arginine-glycine-aspartate) motif 
(Figure 1.7). This PS-Mfge8 complex, when bound through αvβ3 or αvβ5-integrins by 
macrophages induces the internalization of the apoptotic cell by the macrophage and 
its further degradation (Hanayama et al., 2002) (Figure 1.8). 
Mfge8-/- mice show an impaired removal of apoptotic cells from the GC by TBMφs. 
EM-analysis revealed that the TBMφs have several unengulfed apoptotic cells bound 
on their surface indicating an impaired internalization and degradation of these cells. 
Therefore it seems that Mfge8-/- TBMφs can recognize and bind apoptotic cells, but 
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Figure 1.8 Model of Mfge8-dependent engulfment of apoptotic cells. 
Upon apoptosis the dying cell displays PS on its surface. Mfge8 secreted by macrophages 
recognizes PS on the apoptotic cell and opsonizes it for engulfment. Mfge8 is dispensable for the 
attachment (tethering) of the apoptotic cell to the macrophage, but it is essential for the tickling 
(engulfment) of the apoptotic cell. The tickling is mediated by binding of Mfge8 to integrins on the 
macrophage.  
From Zullig and Hengartner, 2004.  
are unable to engulf them (Figure 1.9). Futhermore, these mice were reported to 
have more of GCs and enlarged follicles in the spleen. They also develop 
splenomegaly at old age. The impaired removal of apoptotic cells from the GC of 
Mfge8-/- mice results in systemic lupus erythematosus (SLE) with increased levels of 
anti-doublestrand DNA (dsDNA) and anti-nuclear antibodies (ANA), as well as Ig-
deposits in the glomeruli of the kidney and proteinuria with increased urinary albumin-
levels. This phenotype is rather mild, since it only can be observed in mice of approx. 
40 weeks of age. However, the onset of the disease in Mfge8-/- mice can be 
accelerated by immunization. This induces GCs and therefore increases the 
appearance of apoptotic cells (Hanayama et al., 2004b). The genetic background of 
the Mfge8-/- mice raised some concerns, since the development of the lupus-like 
autoimmunity was described in mice on a B6x129sv mixed background, which often 
develop a spontaneous lupus-like disease. But importantly, it was later claimed that 
the phenotype could be reproduced in mice on a pure C57BL/6 background. 
Interestingly, the autoimmune phenotype was more severe in female than in male 
mice (Hanayama et al., 2006). 
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Figure 1.9 Impaired 
engulfment of apoptotic 
cells in Mfge8-/- mice. 
(A) CD68+ TBMφs of aged 
or immunized Mfge8-/- mice 
show increased numbers 
of attached TUNEL+ 
apoptotic cells. (B) 
Confocal microscopy and 
(C) EM shows that the 
majority of TUNEL+ cells 
that are bound by TBMφs 
are located on the surface 
of the macrophage and not 
inside. This indicates 
impaired engulfment of 
apoptotic cells in the 
absence of Mfge8.  
From Hanayama et al., 
2004b. 
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5.5 Systemic Lupus Erythematosus (SLE) 
SLE is an autoimmune disease that affects several organs, unlike organ-specific 
autoimmune diseases, such as diabetes. Therefore, SLE is classified as a systemic 
autoimmune disease. Consistently, the autoantibodies causing this disease are 
themselves systemic. SLE is characterized by the occurance of autoantibodies that 
target proteins that are present in each cell, such as components of the RNA-splicing 
machinery or chromatin. These autoantibodies are generally referred to as dsDNA 
antibodies or ANA antibodies (Janeway et al., 2001).  
A number of genes have been identified that are involved in the development of SLE. 
Most of these genes can be grouped in four categories. The first category comprises 
genes involved in removal of apoptotic cells from the body, such as C1q (Botto, 1998, 
Walport et al., 1998, Gaipl et al., 2004) or Mfge8 (Hanayama et al., 2004b). Also the 
absence of secreted IgM, which is needed for complement induced clearance of 
dead cells, or the deletion of DNase I, which digests extracellular chromatin, results 
in SLE (Boes et al., 2000, Napirei et al., 2000, Zwart et al., 2004). In line with this, 
patients with SLE caused by an impaired uptake of apoptotic cells by TBMφs have 
been reported (Baumann et al., 2002).  
To the second category belong genes that control B and T cell activation. Among 
these are Fas and Fas ligand (Nagata and Suda, 1995), FcγRIIB, a inhibitory Fc 
receptor on B cells (Bolland et al., 2002) or the cell-cycle inhibitor p21 (Balomenos et 
al., 2000). Genes of the third category control IC-mediated inflammation in affected 
organs. The polymorphic genes FcγRIIa and FcγRIII have different IC-binding 
affinities and are linked with the occurrence of glomerulonephritis (Gibson et al., 
1999). The last category is the hormonal status. Many autoimmune diseases show a 
strong sex bias, what has also been shown for female Mfge8-/- mice, which exhibit a 
more severe disease phenotype (Whitacre et al., 1999, Hanayama et al., 2004b, 
Hanayama et al., 2006). 
While it is clear, that impaired removal of apoptotic cells can lead to SLE, the precise 
mechanism that leads to generation of autoimmune antibodies is not clear, but 
following model has been proposed: When an apoptotic cell is not removed by 
macrophages it undergoes secondary necrosis which is linked with the release of 
chromatin and other nuclear proteins. Secondary necrosis causes inflammation and 
complement activation and possibly opsonization of nuclear debris by complement 
components. The consequences of this might be that opsonized nuclear antigens are 
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taken up and processed by APCs and presented to histone-specific T cells, which in 
turn activate autoreactive dsDNA-specific B cells (Fig. 1.10). Protein-free DNA is 
poorly immunogenic. DNA however, released from necrotic cells is complexed with 
proteins, such as histones, which can be processed and presented to T cells (Moens 
et al., 1995, Rekvig, 1997). Indeed, histone-specific T cells were found in patients 
suffering from SLE (Desai-Mehta et al., 1995, Voll et al., 1997, Mohan et al., 1993). In 
addition to this, FDCs might bind nuclear antigens as ICs and therefore drive 
selection of high affinity antibodies against nuclear antigens (Baumann et al., 2002, 
Gaipl et al., 2005), resulting in the development of a lupus-like autoimmune disease. 
 
Figure 1.10 Model for generation of auto-
antibodies during SLE. 
1) An apoptotic cell that is not removed by 
macrophages undergoes secondary necrosis and 
releases nuclear proteins. 
2) This induces an inflammatory response during 
which the complement system is activated and 
opsonizes the released nuclear proteins. 
3) The opsonized antigens are taken up by APCs, 
processed and displayed via MHC molecules. 
4) APCs then activate autoreactive T cells bearing a 
TCR specific for nuclear antigens. 
5) Activated T cells then in turn activate B cells that 
carry a BCR recognizing nuclear antigen. 
6) After affinity maturation B cells release high affinity 
antibodies directed against nuclear antigens. 
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5.6 Prion diseases 
5.6.1. General aspects of prion diseases 
Prion diseases are fatal transmissible neurodegenerative disorders and are termend 
transmissible spongiform encephalopathies (TSEs). They comprise human diseases 
like Kuru, Creutzfeld-Jakob disease (CJD), fatal familiar insomnia and Gerstmann-
Sträussler-Scheinker syndrome (GSS) (Aguzzi and Polymenidou, 2004, Aguzzi, 
2006), ovine forms like scrapie, bovine spongiform encephalopathy (BSE) in cattle 
(Hope et al., 1989) and chronic wasting disease (CWD) in elk and deer (Sigurdson 
and Aguzzi, 2007). The neuropathological features of TSEs are extensive spongiosis, 
astrogliosis and microgliosis as well as neuronal loss with deposition of large 
extracellular amyloid-like aggregates (Prusiner et al., 1983, Weissmann, 2004). 
The nature of the infectious agent still remains enigmantic. But observations that the 
infectious agent is resistant to UV irradiation, high temperature and formaldehyde 
treatment has led to the protein-only hypothesis which claims that the infectious 
agent consist of protein only and can replicate without nucleic acids. This infectious 
agent has been termed prion (for proteinaceous infectious particle) (Prusiner, 1982). 
The prion is a proteinase-resistant glycoprotein designated PrPSc (for scrapie). PrPSc 
is a postranslationally modified form of the normal cellular prion protein PrPC (for 
cellular) (Bolton et al., 1982, Prusiner et al., 1982). The proteinase-resistancy is a 
useful tool to discriminate between PrPSc and PrPC, but it is questionable that all 
forms of the infectious particle are proteinase-resistant. Indeed, there is evidence 
suggesting that a significant fraction of the infectious particles is proteinase-sensitive 
(Lasmezas et al., 1997). 
PrPC is encoded by the Prnp gene. Strong evidence in favour for the protein-only 
hypothesis was found when this gene was knocked out in mice: Prnp0/0 mice are 
resistant to infection with prions (Sailer et al., 1994). The hope that Prnp-knockout 
mice would also reveal the answer to the question what the physiological function of 
PrPC is, was unfortunately not fulfilled. Although many physiological functions, like for 
example involvement in copper binding and copper metabolism (Brown et al., 1997a, 
Brown et al., 1997b) have been attributed to PrPC, none of these could be 
convincingly demonstrated (Hutter et al., 2003). However, the fact that it is present on 
the cell surface and attached to the cell membrane by a glycophosphatidlyinositol- 
(GPI) anchor might hint to a role in cell adhesion and recognition, ligand binding or 
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transmembrane signaling. The ubiquitous expression of PrPC suggests a rather 
general function with significance to many cell types. In the brain PrPC is expressed 
mainly by neurons, but also by astrocytes and microglia. Outside the CNS PrPC 
expression was found in heart, skeletal muscle, lung, intestines, testis, ovaries and 
lymphoid tissue. The main PrPC expressing cell type in lymphoid tissue are FDCs, 
but also hematopoietic cells express low levels of PrPC (McBride et al., 1992). 
 
6.6.2 Conversion of PrPC to PrPSc 
The conversion of PrPC to PrPSc is incompletely understood. At present there are two 
major models describing the mechanistic features of the PrPC to PrPPSc conversion: 
The “refolding” or “template assistance” model (Fig. 1.11A) suggests that the 
spontaneous conversion of PrPC to PrPSc is prevented by an energy barrier. Only if 
PrPC interacts with an existing PrPSc molecule the conversion process can be 
initiated. Once a PrPC:PrPSc heterodimer is formed the catalytic activity of PrPSc 
Figure 1.11 “Refolding” and “Seeding” models for the conversion of PrPC into PrPPSc.  
(A) The `refolding' or “template assistance” model postulates that PrPC interacts with PrPSc 
introduced from outside. PrPSc induces the conversion of PrPC into new PrPPSc molecules. 
Spontaneous conversion of PrPC to PrPSc is prevented by a high energy barrier.  
(B) The `seeding' model postulates that PrPC and PrPSc form a reversible thermodynamic 
equilibrium. Only after several monomeric PrPPSc molecules are organized into a highly ordered 
seed, further monomeric PrPSc molecules can be recruited to the seed, resulting eventually in 
amyloid. PrPSc becomes stabilized in such a seed. Fragmentation of PrPScP  aggregates results in 
new seeds. From Aguzzi and Sigurdson, 2004. 
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reduces the energy needed for the conversion of PrPC to PrPSc (additional enzymes 
or chaperones might be required for this process). Therefore, the formation of a PrPSc 
homodimer is now possible. The newly formed PrPSc can then function itself as 
template resulting in an exponential increase of PrPSc. The slowest step in this model 
is the conversion itself, which might require extensive unfolding and refolding of the 
protein (Gajdusek, 1988, Prusiner and DeArmond, 1990, Prusiner, 1991). 
The “seeding model” (Fig. 1.11B) claims that the conversion is reversible and 
controlled thermodynamically. The transition of PrPC to PrPSc occurs spontaneously 
but the thermodynamically favoured form is PrPC. After spontaneous formation of 
monomeric PrPSc, the newly formed PrPSc can be stabilized when it interacts with a 
crystal-like seed or aggregates of PrPSc. In this model the rate limiting step is the 
seed-formation (Come et al., 1993, Jarrett and Lansbury, 1993, Lansbury and 
Caughey, 1995).  
Both models are not mutually exclusive and can be applied to both inherited or 
infectious forms of prion diseases. In inherited forms, a mutation in the Prnp gene 
may change the ability of spontaneous formation of infectious PrPSc or PrPSc 
aggregates that function as a seed for polymerization. In infectious prion diseases 
the incoming PrPSc might resemble either the PrPSc catalyzing the transition from the 
heteordimer to the PrPSc homodimer or the polymerization-seed.  
 
6.6.3 Prions and the immune system 
In natural scrapie infections the infectious prions are normally not directly transmitted 
to the CNS. Typical entry of prions occurs rather through the oral route via food 
intake or via skin (scarification). Before prions reach the brain they have to travel 
from the entry site to the CNS, in a process called neuroinvasion (Aguzzi, 2003). 
During the first stage in their travel prions have to leave the gut and enter the 
lymphoid system. In sheep that where orally inoculated with prions to mimic the 
natural situation, prions were first recovered from the distal ileum after oral challenge 
(Wells et al., 1994, van Keulen et al., 1996). It was further observed that PPs were 
able to accumulate large amounts of prions. Prinz et al. could show that the 
susceptibility of mice to oral inoculation correlated with their number of PPs (Prinz et 
al., 2003b). Furthermore, Heppner et al. were able to show that M cells play a central 
role in transporting prions to PPs (Heppner et al., 2001). M cells are located in the 
follicle-associated epithelium of the PPs and are specialized in the uptake and 
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transcytosis of macromolecules and microorganisms (Hathaway and Kraehenbuhl, 
2000). Once prions have entered the lymphoid system, they spread to all lymph 
nodes and the spleen, where they are replicated efficiently. High titres of prions can 
be recovered from the lymphoid organs long before they can be detected in the brain 
(Kimberlin and Walker, 1979, Mabbott et al., 1998). Several cell types of the immune 
system might be involved in replication and transport of prions in lymphoid organs. B 
cells, macrophages and dendritic cells might be important for prion transport, but less 
important for prion replication. One major cell type has been identified that is 
responsible for prion replication and accumulation in lymphoid organs. This cell type 
is the FDC. FDCs express high levels of PrPC, much higher levels than any other cell 
type of the lymphoid system (Jeffrey et al., 2000). Mice devoid of FDCs are resistant 
to prion disease after peripheral administration of prions. Also a temporary depletion 
of FDCs by injection of soluble LTβR-Ig treatment during the time of infection renders 
mice resistant to peripherally administered prions. Initially, it was believed that B cells 
are the most important cell type for peripheral prion replication, since mice devoid of 
B cells where unable to replicate prions in their lymphoid organs (Klein et al., 1997). 
But now all evidence points towards an indirect role of B cells in prion replication. B 
cells provide essential survival and differentiation signals to FDCs via LT and TNF. 
Their presence is indispensable for normal FDC maturation and therefore for efficient 
peripheral prion replication (Aguzzi, 2003). 
FDCs can even render the organ tropism of prions, when they appear ectopically in 
tertiary follicles. Normally liver and kidney are free of prions, but Heikenwälder et al., 
could show that upon transgenic expression of LTα and LTβ in these organs FDC-
containing tertiary follicles arise. When these mice were inoculated with prions, high 
titres of prions were recovered from liver and kidney (Heikenwalder et al., 2005). 
Visualization of prion accumulation in lymphoid organs by histoblot, (a technique 
where tissue is blotted onto a membrane, digested with proteinase K to remove 
cellular PrPPC and then incubated with anti-PrP antibodies) shows that all detectable 
PrPSc perfectly colocalizes with FDCs (Fig. 1.12).  
Why are FDCs such efficient prion replicators? There are several possible reasons. 
Their high expression of PrPC is certainly of importance. But apart from that FDCs 
exhibit several other features that might make them so unique in their ability to 
replicate prions. One such feature is their expression of complement receptors. There 
is a large body of evidence that the complement system has a key role in enabling 
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Figure 1.12. Histoblot of a prion infected spleen. 
A splenic cryosection was blotted onto a nitrocellulose membrane, digested with proteinase K and 
incubated with anti-PrP antibodies. Disease associated PrPSc can only be detected in white pulp 
follicles and colocalizes with FDCs. 
peripheral prion replication. Mice deficient of components of the complement system, 
like C1q, C3 or C4 knockout mice, or mice deficient of complement receptors (like 
CD21/35 knockout mice) all show substantially impaired peripheral prion replication 
(Klein et al., 2001). Also temporary inactivation of complement C3 by cobra venom 
significantly impaired peripheral prion replication and delayed the onset of the 
disease in mice (Mabbott et al., 2001). Recently, Zabel et al., where able to show by 
reciprocal BM-chimeras that only the depletion of CD21/35 on FDCs, but not on B 
cells significantly impaired prion replication in lymphoid organs, underlining the 
importance of complement receptor expression by FDCs (Zabel et al., 2007). These 
results suggest that once prions enter the body they activate the complement system 
and become opsonized by soluble complement factors and can then be bound by 
FDCs through their complement receptors. 
One additional feature of FDCs that might contribute to their ability to replicate prions 
is their longevity and the fact that they do not undergo extensive cell division. Recent 
results from the lab of Charles Weissmann indicate that in vitro prions are mainly 
transmitted horizontally from the parental cell to the daughter cell rather than to 
neighboring cells. In vitro replication is most efficient if cell division is slowl, because 
after each division the prion load in each cell is reduced by 50%. If the rate of cell 
division is too fast, the prion load in each cell is continuously decreased with each 
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round of cell division until the prions are completely cleared from the cell. It is likely 
that this also holds true for the in vivo situation. This might also explain why neurons 
are also very efficient prion replicating cells, they are also very long-lived and hardly 
undergo cell division. 
But how do prions travel from lymphoid organs to neurons located in the CNS? 
Substantial evidence suggests that prions migrate along peripheral nerves from the 
lymphoid system to the CNS. This migration is dependent on PrPC expression by 
peripheral nerves (Aguzzi, 2003). Lymphoid organs are highly innervated with 
sympathetic nerves (Felten and Felten, 1988). Denervation or sympathectomy 
significantly delayed the onset of prion pathogenesis by impairing the transport of 
prions from the lymphoid organs to the CNS (Glatzel et al., 2001). A study conducted 
by Prinz and Heikenwälder et al. showed that the distance between FDCs and 
peripheral nerves determines the velocity with which prions are able to enter the CNS 
(Prinz et al., 2003a). 
Figure 1.13 Prion accu-
mulation in an infected animal. 
After ingestion of prions, they 
travel along the gastrointestinal 
tract to pancreas, lymphoid 
organs and muscle, then continue 
their travel along peripheral 
nerves to the CNS. From Aguzzi 
and Sigurdson, 2004. 
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5.7 Outline of this study 
A detailed understanding of FDC biology is not only important because FDCs are a 
central component of the GC reaction and therefore for adaptive immunity in general, 
a detailed understanding of FDC development and function is also needed, because 
they are involved in diseases like prion diseases as described above. But prion 
diseases are not the only situation where FDCs play a noxious role: Upon infection 
with HIV, FDCs trap large numbers of infectious virions for months if not years 
(Tenner-Racz et al., 1988). Hence, FDCs represent a viral reservoir in close contact 
to CD4+ T cells that can become subsequently infected. Therefore, FDCs render the 
GC conducive to HIV replication, thereby contributing to the pathogenesis of AIDS.  
Due to the central role of FDCs in the replication of prions, Huber et al. performed a 
transcriptomic mircroarray analysis in order to identify FDC-specific genes. For this, 
isolated FDCs were compared to spleens that were devoid of FDCs due to treatment 
with soluble LTβR-Ig fusion protein (Huber et al., 2005).  
The aim of this unbiased transcriptomic screen was to identify new genes that were 
important to FDC biology and that would give new insights into the function of FDCs 
in health and disease. One interesting candidate that was identified by this screen 
was Mfge8. 
The aim of the study presented here was to determine the function of Mfge8 in FDCs. 
The first step was to clarify the origin of Mfge8 in the spleen, since Hanyama et al., 
claimed TBMφs rather than FDCs as the source of splenic Mfge8.  
In order to solve this, FDCs of Mfge8-/- mice were first analysed histologically. FDCs 
from Mfge8-/- mice seemed to be morphologically normal despite the fact that they 
lacked expression of the FDC-marker FDC-M1. This raised the possibility that Mfge8 
and FDC-M1 are identical, which was then confirmed by several independent 
techniques.  
In the second part of this study the question whether FDCs, TBMφs or both cell types 
express Mfge8 was addressed by generating BM-chimeric mice between wild-type 
(WT) and Mfge8-/- mice and in situ hybridization (ISH) techniques. This approach 
identified FDCs as the sole source of Mfge8 in the spleen. 
Next, the question whether the phenotypes observed in the Mfge8-/- mice, like 
impaired removal of apoptotic cells from the GC and the development of SLE can be 
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attributed to lack of Mfge8 expression by FDCs was addressed by using BM chimeric 
mice. 
The last part of this study deals with the question, whether Mfge8 produced by FDCs 
is involved in prion replication or accumulation by these cells. 
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6 Results 
6.1 Mfge8 and FDC-M1 are identical 
6.1.1 FDC-M1+ networks are absent in spleens of Mfge8-/- mice 
The results of the microarray screen performed by Huber et al. suggested that FDCs 
express Mfge8 (Huber et al., 2005). This could be confirmed by immunofluorescence 
(IF) using an anti-Mfge8 antibody (Figure 6.1). The dense reticular network formed by 
FDCs clearly stained positive for Mfge8. Furthermore, some cells lining the marginal 
zone were weakly positive for Mfge8. Within the follicle all staining was restricted to 
the B-cell zone, the T-cell zone in the center of the follicle and also the red pulp did 
not show any Mfge8+ cells by IF (Fig. 6.1). 
 
Since Mfge8 was so abundantly expressed on FDCs, Mfge8-/- mice were analyzed in 
order to define the role of FDC-borne Mfge8. Although the splenic microarchitecture 
of Mfge8-/- mice was altered with enlarged TBMφs, progressive splenomegaly, and 
hyperplastic follicles with increased numbers of PNA+ GCs, FDC abnormalities were 
not reported (Hanayama et al., 2004b). However, a complete absence of FDC-M1+ 
networks from splenic cryosections of Mfge8-/- mice was observed when stained with 
the anti-FDC-M1 antibody 4C11 (Figure 6.2A). Expression of other FDC markers, 
including CD21/35 (Fig. 6.2A) or FDC-M2 (data not shown), did not differ between 
Mfge8-/- and WT mice.  
Figure 6.1 Immunofluorescent 
staining of FDCs using an anti-
Mfge8 antibody. 
High Mfge8 expression can be 
found on FDC networks. Some 
single cells around the FDC 
network stain weakly positive for 
Mfge8. These cells could 
resemble TBMφs. Also cells 
lining the marginal zone stain 
weakly positive for Mfge8. 
Almost no Mfge8+ cells can be 
found in the T-cell zone of the 
follicle or the red pulp. 
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Figure 6.2 FDCs are present in Mfge8-/- mice but do not express FDC-M1.  
(A) IHC of spleens from WT and Mfge8-/- mice were analyzed for CD21/35 and FDC-M1 
expression by light microscopy. FDC-M1+ networks are absent in Mfge8-/- mice. Scale bar: 100 
μm. (B) EM of isolated FDC-enriched clusters showing an FDC (dotted line) surrounding 
lymphocytes (L). There are no obvious morphological differences between FDC-lymphocytes 
aggregates from WT and Mfge8-/- mice. Scale bar: 2.90 μm 
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This lack of 4C11 immunoreactivity in Mfge8-/- spleens could result either from 
absence of mature FDCs, or from FDC-M1 antigen in FDCs. Therefore, FDC-
enriched clusters of WT and Mfge8-/- mice were analyzed by EM. FDC clusters were 
identified as multicellular aggregates with FDCs encircling lymphocytes by long 
dendritic cytoplasmic extensions. WT and Mfge8-/- FDCs were ultrastructurally 
indistinguishable in isolated FDC-enriched clusters (Fig. 6.2B). Therefore, Mfge8 
ablation abrogates 4C11 immunoreactivity but does not eliminate mature FDCs, 
either because Mfge8 and FDC-M1 are identical, or because Mfge8 is involved in the 
regulation of FDC-M1 expression.  
 
6.1.2 Mammary epithelial cells express FDC-M1 
If FDC-M1 and Mfge8 are the same antigen, then FDC-M1 immunoreactivity might be 
expected in all tissues known to express Mfge8, including the mammary gland which 
upregulates Mfge8 expression after weaning (Nakatani et al., 2006). Mfge8 is 
localized on the membrane of mammary epithelial cells and in the alveolar lumen 
where milk fat globules accumulate (Nakatani et al., 2006). Hence, mammary glands 
of lactating WT or Mfge8-/- mice were examined by IF with 4C11 or the anti-Mfge8 
antibody 18A2-G10 (Miyasaka et al., 2004). Membranes of mammary epithelial cells 
were 4C11+ and showed a high degree of colocalization with Mfge8 (Fig. 6.3A). 
Importantly, 4C11 immunoreactivity was absent in Mfge8-/- mammary glands.  
6.1.3 4C11 immunolabeling of spleen and mammary gland is blocked by recombinant 
Mfge8 
To investigate whether the staining of FDC-M1 and Mfge8 can be abrogated by pre-
incubation of antibodies with recombinant Mfge8 (rMfge8), 18A2-G10 and 4C11 were 
pre-incubated with an excess of rMfge8 before applying them to mammary-gland 
cryosections obtained from lactating WT mice (Fig. 6.3B). Pre-incubation with 
rMfge8, but not with rEGF (epidermal growth factor), completely abolished staining of 
both 18A2-G10 and 4C11. The results of this competition assay provided evidence 
that the FDC-M1 antigen is Mfge8. 
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Figure 6.3 Mammary epithelial cells express FDC-M1.  
(A) Cryosections of involuting mammary glands from lactating WT and Mfge8-/- mice were 
analyzed for Mfge8 and FDC-M1 expression by IF. Two-color stains of WT mammary glands 
with 18A2-G10 (green) and 4C11 (red) were performed. Immunoreactivity for both antibodies 
was observed on the membrane of mammary epithelial cells and within the alveolar lumen. 
The overlay shows high degree of colocalization. Scale bar: 50 μm. (B) Pre-incubation of 
18A2-G10 or 4C11 with 25 μg/ml rMfge8, but not rEGF, blocked the staining. Scale bar: 200 
μm. 
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Figure 6.4 FDC-M1 and Mfge8 show 
a high degree of colocalization. 
Spleens from WT mice were analyzed 
by IF. The upper panel shows double-
staining of the same section with 
either 18A2-G10 (green) and 4C11 
(red) and the lower panel double- 
staining with 2422 (green) and 4C11 
(red). Both anti-Mfge8 antibodies 
show a high degree of colocalization 
with 4C11. 
Next, immunofluorescent analysis of Mfge8 expression in the spleen was performed. 
Two-color labeling of splenic cryosections revealed a very high degree of 
colocalization between 4C11 and anti-Mfge8 antibodies (18A2-G10 or 2422) 
(Hanayama et al., 2004b) on FDCs (Fig. 6.4).  
To assess whether rMfge8 would compete with 4C11 in spleen 18A2-G10 or 4C11 
antibodies were pre-incubated with rMfge8. Only pre-incubation with rMfge8, but not 
with rPrP (which was chosen, because PrP is a protein also abundantly present on 
FDCs) or rEGF (which was chosen because Mfge8 contains an EGF domain), 
Figure 6.5 rMfge8 competes with 4C11 for binding to FDCs. 
Pre-incubation of 18A2-G10 or 4C11 with 25 μg/ml rMfge8 blocks the staining of FDCs by these 
antibodies. To visualize FDCs, sections were stained with the anti-PrP antibody POM2 directly 
conjugated to Cy5. When 18A2-G10 antibody and 4C11 were pre-incubated with rEGF or rPrP, the 
staining of FDCs was not affected. Scale bar: 100 μm. 
 
significantly reduced their ability to stain splenic FDCs (Fig. 6.5), providing further 
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evidence that Mfge8 is the FDC-M1 antigen. Since rMfge8 binds to PS (Hanayama et 
al., 2002), the observed increase in background signal may be a result of binding of 
rMfge8-antibody immunocomplexes to PS globally exposed on membranes.  
PrPC is abundantly expressed on FDCs (McBride et al., 1992) and was therefore 
6.1.4 The anti-Mfge8 antibody 2422 and 4C11 compete for binding to FDCs 
nd then 
used to visualize the presence of FDCs. In contrast to FDC-M1, pre-incubation of 
FDC-M2 with rMfge8 did not impair the immunolabeling of FDCs (data not shown). 
Although binding of 4C11 to FDCs was abolished by competitive pre-incubation with 
rMfge8, its affinity may be lower than that of 18A2-G10, since 10 μg/ml rMfge8 only 
partially inhibited the FDC staining by 4C11 yet completely inhibited that of 18A2-G10 
(data not shown).  
When spleen sections were pre-incubated with anti-Mfge8 antibody 2422 a
stained with fluorescently labeled 4C11, the 4C11 signal was completely abolished 
(Fig. 6.6, upper panel). Conversely, after pre-incubation of the sections with an 
excess of 4C11, FDC staining by 2422 was reduced (Fig. 6.6, middle panel). When 
both antibodies were applied simultaneously onto the section, both antibodies 
Figure 6.6 rMfge8 competes with FDC-M1 for the binding to FDCs. 
Spleen-cryosections were first stained with 2422 (green). When after washing
incubated with 4C11 (red) no binding was observed (upper panel). W
 sections were 
hen an excess of 4C11 
was applied before 2422, binding of the latter was abolished (middle panel). When the two 
antibodies were applied onto the sections concomitantly, both antibodies were able to stain 
FDCs (lower panel). Scale bar: 20 μm. 
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recognized FDCs (Fig. 6.6, lower panel). This observation indicates that the 
antibodies 2422 and 4C11 compete with each other for Mfge8, possibly because they 
recognize the same epitope, or sterically incompatible epitopes.  
6.1.5 The anti-Mfge8 antibody 2422 and FDC-M1 compete for binding to rMfge8 
The molecular details of the competition between 2422 and 4C11 for rMfge8 were 
analyzed by surface plasmon resonance (SPR). First, 4C11, or rat IgG2c isotype 
control antibody were covalently immobilized on the sample and control flow cell of a 
sensor chip surface, respectively. Then recombinant proteins (rEGF, rPrP, rMfge8, 
50 μg/ml each) were injected into both flow cells, and association and dissociation 
sensograms for each recombinant protein were recorded after subtraction of the 
respective interactions with the isotype control-coupled surface. No deviation from 
the baseline was observed after injection of rEGF or rPrP (indicated by black arrows) 
on the 4C11-coated chip (Fig. 6.7, panels A and B), indicating that no interaction 
occurred between these proteins and the coated 4C11 antibody. Conversely, 
injection of rMfge8 resulted in a rapid increase of resonance units (RU) in the 4C11-
coated flow cell during the injection phase, suggesting specific interactions.  
To test whether the association could be confirmed in a reverse orientation 
(interaction of 4C11 with a rMfge8-coated surface), rMfge8, or rPrP for control, were 
covalently conjugated to two continuous flow cells (data not shown). In four 
subsequent injections an interaction of 4C11 with the immobilized rMfge8 was 
observed, as evidenced by an increase in RUs (Fig. 6.7, panel C). No RU increase 
was observed between the third and the fourth 4C11 injection, indicating that binding 
of 4C11 to rMfge8 had reached saturation. When 2422 was subsequently injected 
onto the chip, binding was minimal (Fig. 6.7, panel C, arrow “2422”). 18A2-G10 was 
then injected, and resulted in a strong RU increase, indicating an interaction with the 
rMfge8-coated flow cell (Fig. 6.7 panel C, arrow). As expected, rat IgG2c did not bind 
to immobilized rMfge8 (data not shown).  
After regenerating the chip with 100 mM HCl, the antibodies were re-injected on the 
rPrP- and rMfge8-coated flow cells in a different order. 2422 was injected first in two 
consecutive injections, allowing saturation of rMfge8 binding (Fig. 6.7 panel D). When 
4C11 was then injected onto the 2422-covered flow cell, it did not bind to rMfge8 (Fig. 
6.7 panel D, 4C11-indicated injection). In contrast, 18A2-G10 always bound to 
rMfge8 regardless of any previously bound 2422 or 4C11 (Fig. 6.7 panel C and D). 
Hence, the 18A2-G10 epitope is distinct from those of the other two antibodies. Along  
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Figure 6.7 Anti-Mfge8 antibody 2422 competes with FDC-M1 for binding to rMfge8 in SPR 
experiments. 
In panels (A) and (B) sensograms show binding of rMfge8, but not rEGF or rPrP respectively, to 
immobilized 4C11, covalently bound on CM5 Biacore chip. Red arrows indicate the end of rMfge8 
injection. In panels (C) and (D) rMfge8 and rPrP (as negative control) were covalently coupled to 
sample and control flow cell, respectively. (C) In four subsequent injections, 4C11 bound to 
immobilized rMfge8 until an apparent saturation level. 2422 was subsequently injected on the 
rMfge8-covered surface, resulting in minor increase in resonance units (RUs). The following 
injection of 18A2-G10 shows a strong interaction with rMfge8. (D) After regeneration with 100mM 
HCl (not shown), 2422 was injected onto the chip showing a strong interaction in two successive 
injections. Subsequent injection of 4C11 resulted in minimal binding to rMfge8. In contrast, 18A2-
G10’s binding to rMfge8 was not affected by previous injections. (E) 18A2-G10 was covalently 
bound to the chip surface and was able to capture rMfge8. When 18A2-G10 was then injected, no 
binding was observed, since all of its epitopes on rMfge8 are occupied by the immobilized moiety. 
In contrast, 4C11 could efficiently bind to the rMfge8 captured surface. Next, 2422 was injected 
onto the chip, but showed no binding to rMfge8, due to a competition effect of 4C11. (F) After 
regeneration (not shown), and capture of rMfge8 on the chip surface, 2422 was injected, this time 
showing a strong interaction. 4C11, which was injected next did no longer bind to Mfge8. 
For control, injections of all proteins were made on two flow cells, where the first flow cell was 
coated with control protein or antibody and the second with the protein/antibody of interest. 
Sensograms show binding of each recombinant protein/antibody after subtraction of their binding 
to control antibody/protein-coupled surface. Black arrows indicate the beginning of the indicated 
injection. Inserts are schematic representations of binding and competition events of the 
sensogram in the respective panel. 
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with the immunofluorescent competition experiments (Fig. 6.6), these results indicate 
that 4C11 and 2422 abrogate each other’s binding to Mfge8. Thus, 4C11 and 2422 
share a common or overlapping epitope, or recognize Mfge8 epitopes which sterically 
hinder each other.  
Further evidence for this hypothesis came from the next setup, where 18A2-G10 was 
immobilized on a new flow cell. rMfge8 readily bound to the non-competing antibody. 
A third injection was performed with one of the three antibodies 18A2-G10, 2422, and 
4C11 in a sandwich-like design. Under these conditions, injected 18A2-G10 did not 
bind to the surface decorated with 18A2-G10-captured rMfge8, confirming that 18A2-
G10 binds to a single non-repeating epitope on Mfge8 (Fig. 6.7 panel E). Subsequent 
injection of 4C11 resulted in a strong interaction with captured rMfge8. When 2422 
was injected, no binding occurred. Then the order of injection was reversed. After 
capturing of rMfge8 by immobilized 18A2-G10, 2422 was injected first, followed by 
injection of 4C11. In this case, the first antibody 2422 interacted with 18A2-G10-
captured rMfge8, but not 4C11 due to competition with the former antibody (Fig. 6.7, 
panel F).  
6.1.6 The antibody 4C11 immunoprecipitates Mfge8 
2422 has been previously reported to be able to immunoprecipitate Mfge8 
(Hanayama et al., 2002). In order to assess whether 4C11 immunoprecipitates 
Mfge8, 4C11, 2422, or rat IgG2c isotype control antibodies were conjugated to 
tosylactivated paramagnetic beads. These were then exposed to protein extracts of 
WT or Mfge8-/- spleens. Precipitated proteins were analyzed by Western blotting with 
anti-Mfge8 antibody 18A2-G10. Following immunoprecipitation with 2422-coated 
beads, two Mfge8-specific bands were detected with molecular weights of 
approximately 45 and 55 kDa (Fig. 6.8). In the immunoprecipitates derived using 
4C11 beads, two Mfge8-specific signals were obtained with molecular weights 
matching those of the 2422-immunoprecipitation (Fig. 6.8). These signals were 
absent in spleens from Mfge8-/- mice, confirming the specificity and identity of bands 
observed in immunoprecipitates from WT protein extracts.  
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Figure 6.8 FDC-M1 immunoprecipitates Mfge8 from mouse spleen homogenates. 
Splenic protein extracts from WT and Mfge8-/- mice were immunoprecipitated with paramagnetic 
beads conjugated to anti-Mfge8 antibody 2422, 4C11 or to a rat IgG2c isotype control antibody. 
Beads coupled with 2422 or 4C11, but not exposed to splenic protein extracts were included as 
controls. The Western blot was probed with anti-Mfge8 antibody 18A2-G10. In WT, but not in 
Mfge8-/- samples immunoprecipitated with either 2422 or 4C11, two Mfge8-specific signals were 
visible (marked with * and x). Additional non-Mfge8-specific bands possibly representing hamster 
and rat immunoglobulin fragments (red arrows), and a 37 kDa band of unknown identity (black 
arrow), reacted with the secondary antibody only (data not shown).  
 
 
 48
Results 
_____________________________________________________________________________________________________ 
6.2 FDCs and not TBMφs are the major source of Mfge8 in the spleen 
6.2.1 Analysis of Mfge8 expression in BM chimeric mice 
In contrast to the above findings, it has previously been reported that within splenic 
follicles Mfge8 is exclusively produced by TBMφs (Hanayama et al., 2004b). To 
address this discrepancy, and to investigate whether Mfge8 might be secreted by 
TBMφs and trapped by FDCs or vice versa, reciprocal BM chimeras between Mfge8-/- 
and WT mice were used. FDCs are stromal and radiation resistant (Kapasi et al., 
1998), whereas TBMφs are mononuclear phagocytes of hematopoietic origin and are 
thought to be radiation sensitive (Flemming, 1885, Humphrey et al., 1984), therefore, 
analysis of these BM-chimeric mice should enable to determine the origin of Mfge8 in 
lymphoid organs. To provide an independent marker of histogenesis, lethally 
irradiated Mfge8-/- mice expressing the CD45.2 allele were reconstituted with BM 
from CD45.1 congenic WT mice, and vice versa (Fig. 6.9).  
In case both cell types express Mfge8, then WT mice reconstituted with Mfge8-/- BM 
(Mfge8-/-→WT) should only show Mfge8 expression by FDCs, while the 
hematopoietic TBMφs are expected to lack Mfge8 expression. In the reverse situation 
(WT→Mfge8-/- ) only the BM derived TBMφs should express Mfge8, but not the 
stromal FDCs (Fig. 6.9).  
Figure 6.9 Scheme of BM-reconstitutions. 
BM of Mfge8-/- or CD45.1 congenic WT donors 
was isolated and injected into lethally irradiated 
WT (Mfge8-/-→WT) or Mfge8-/- (WT→Mfge8-/-) 
hosts, respectively. WT→WT and Mfge8-/-
→Mfge8-/- chimeras served as controls.  
In case both cell types express Mfge8, following 
phenotype was expected: 
In Mfge8-/-→WT mice only FDCs, but no TBMφs 
are expected to express Mfge8 and in 
WT→Mfge8-/- mice only TBMφs, but not FDCs 
should express Mfge8. 
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Figure 6.10 Assessment of reconstitution efficiency. 
(A) Efficiency of the BM-transfer was assessed by FACS-analysis on peripheral blood collected 
five weeks after BM-transfer. Cells were stained with antibodies against CD45.1 and CD45.2. 
Dot plots show the frequency of CD45.1+ and CD45.2+ cells. Percentage of cells within the 
different quadrants is given in each quadrant. Dot plots shown are representative for ten 
CD45.1→Mfge8-/- and nine Mfge8-/-→CD45.1 mice. Reconstitution efficiency for all reconstituted 
mice is shown as percentage of donor cells. Average efficiency for CD45.1→Mfge8-/- was 95.5% 
± 3.2% and for Mfge8-/-→CD45.1 92.1% ± 3.2%. Values are given as mean ± SD. 
(B) Spleen-cryosections were subjected to three-color immunolabeling with antibodies against 
CD45.2 (green), CD45.1 (red) and CD68 (cyan). Specificity and background levels of the CD45.2 
and CD45.1 immunostains were determined on WT→WT and Mfge8-/-→Mfge8-/- spleen sections 
(panel 1 and 2). CD68+ TBMφs did not colocalize with the few observed host-derived CD45.1+ 
(Mfge8-/-→WT) or CD45.2+ (WT→Mfge8-/-) cells. White squares outline the area shown in higher 
magnification. Scale bar column 1: 100 μm, column 2-5: 20 μm. 
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Five weeks after reconstitution the average efficiency was 93.8±3.6% as assessed by 
flow-cytometric analysis of CD45.1  and CD45.2  cells in peripheral blood confirming 
a successful reconstitution (Fig. 6.10A). The donor origin of TBMφs was confirmed by 
multi-color IF using antibodies against CD45.1, CD45.2 and CD68 to rule out the 
possibility that they had survived the lethal irradiation (Fig. 6.10B). The specificity of 
the CD45.1 and CD45.2 antibodies was determined by staining Mfge8 →Mfge8  (all 
CD45.2 ) and WT→WT (all CD45.1 ) spleens with anti-CD45.1 (red) and anti-CD45.2 
(green) antibodies, respectively. No cross-reactivity was observed (Fig. 6.10B, 1  
and 2  panel). Two-color immunolabeling of Mfge8 →WT spleens with anti-CD68 
(cyan) and the host-cell marker CD45.1 (red) confirmed that TBMφs were not host-
derived (Fig. 6.10B 3  panel). Consequently, TBMφs of WT→Mfge8 spleens did not 
express the host-cell marker CD45.2 (Fig. 6.10B 4  panel). Therefore, in all chimeras 
TBMφs originated from donor BM and were not of host origin, although occasionally 
few host-derived cells were present in some follicles. 
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Figure 6.11 Quantitative PCR expression analysis of Ptprc in FDC-enriched cell clusters.  
FDC-enriched clusters were co-isolated with GC B cells by MACS-sorting using biotinylated 4C11 
antibody and anti-biotin magnetic beads. After RNA isolation cDNA of the FDC-enriched and the 
flow-through fraction was synthesized. Mfge8, Cxcl13 and Ptprc expression levels in cell-fractions 
of three independent isolations (using lymph nodes of 5 mice per isolation) were determined by 
quantitative RT-PCR (qPCR). Expression levels are shown as ratio of FDCs vs. flow-through. 
Mfge8 expression in FDCs was increased 7.3 ± 2.7 fold, Cxcl13 expression was increased 6.0 ± 
2.9 fold and Ptprc levels were reduced 4.1 ± 0.2 fold as compared to the flow-through fraction. 
Values are given as mean ± SD. 
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Early analyses of BM chimeras were taken to suggest a hematopoietic derivation of 
FDCs (Kapasi et al., 1998), but most evidence favors a stromal origin (Groscurth, 
1980, Dijkstra et al., 1984, Humphrey et al., 1984, Yoshida et al., 1995). Therefore, 
FDCs may not express CD45, which is a strictly hematopoietic marker (Ledbetter and 
Herzenberg, 1979). This may be the reason why FDCs failed to show expression of 
the host CD45 allele in these BM chimeras. To support this idea, FDC-enriched 
versus FDC-depleted fractions were analayzed after MACS-sorting of FDCs as 
described previously (Sukumar et al., 2006). Expression of Ptprc (the gene encoding 
for CD45) was markedly reduced in the FDC-enriched fraction, whereas FDC-specific 
genes like Mfge8 and Cxcl13 were increased (Fig. 6.11). The residual CD45 
expression probably resulted from B cells that were co-isolated with the FDC-
clusters. These results support the hypothesis that FDCs do not express CD45 and 
explain why they were not identifiable as host-derived cells in CD45.1/CD45.2 
immunolabelings. 
Prior to the analysis, the BM-chimeric mice were immunized with ovalbumin (OVA) in 
alum six and eight weeks after reconstitution to induce GC formation. Nine weeks 
post reconstitution, splenic Mfge8 and CD68 expression was analyzed by IF of 
cryostat sections. Surprisingly, Mfge8-/- mice receiving WT BM (WT→Mfge8-/-) 
Figure 6.12. Analysis of splenic Mfge8 expression by IF. 
Splenic cryosections from Mfge8-/- mice reconstituted with WT BM (upper panel) and from WT 
mice reconstituted with Mfge8-/- BM (lower panel) were immunostained with anti-Mfge8 antibodies 
(clone 2422, green) and anti-CD68 antibodies (red). Immunoreactivity of the Mfge8 antibody on 
FDCs and CD68+ TBMφs was only observed when FDCs were of WT origin. Figures show areas 
inside follicles. White square marks the area shown in higher magnification. Scale bar: 20 μm. 
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Figure 6.13. Analysis of splenic Mfge8 expression by ISH.  
Splenic Mfge8 expression was assessed using ISH (left column). Adjacent sections were 
immunolabeled with 4C11 (middle column) and anti-CD68 antibodies (right column). Mfge8 
expression and 4C11 immunostaining was only found in WT mice irrespective of the BM genotype 
(panel 1 and 3). Mfge8-/- mice that received BM from either Mfge8-/- mice or from WT mice showed 
no Mfge8-specific signal after ISH and no 4C11 immunostaining. Presence and localization of 
TBMφs is shown by the CD68 immunostaining. Scale bar: 100 μm. 
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lacked all Mfge8 immunoreactivity in spleens. Not only radiation resistant FDCs, but 
also BM-derived CD68+ TBMφs were negative for Mfge8, although they had clearly 
originated from WT donors (Fig. 6.12 upper panel). In contrast, spleens of WT mice 
reconstituted with Mfge8-/- BM (Mfge8-/-→WT) contained not only Mfge8+ FDCs, but 
also Mfge8-immunostained TBMφs originating from Mfge8-/- donors (Fig. 6.12 lower 
panel). In all samples, Mfge8+ TBMφs were visible whenever FDCs expressed Mfge8, 
yet were always Mfge8- whenever FDCs did not express Mfge8. 
Next, the transcriptional pattern of splenic Mfge8 was determined by RNA ISH. In 
WT→WT mice, Mfge8 transcription was restricted to follicles (Fig. 6.13, upper panel). 
The strongest expression was found in the GC, where FDCs reside. Some Mfge8+ 
cells surrounded follicles. These cells were radiation resistant, and may represent 
immature FDC precursor cells, as proposed previously (Pasparakis et al., 2000). 
Overall, the ISH visualized more Mfge8+ cells than the FDC-M1 IHC, probably due to 
the higher sensitivity of the riboprobe. 
Adjacent sections were immunostained with 4C11 and anti-CD68 antibodies. 
However, both Mfge8 immunostains and Mfge8 ISH visualized characteristic FDC 
networks, confirming that Mfge8 is indeed produced by FDCs, rather than being 
secreted by other cell types and taken up by FDCs (Fig. 6.13 upper panel). No signal 
was detected after ISH on Mfge8-/-→Mfge8-/- spleens, confirming the specificity of the 
Mfge8 in situ riboprobe (Fig. 6.13, 2nd panel). 
The Mfge8 expression pattern in Mfge8-/-→WT chimeras was identical to that of WT 
mice (Fig. 6.13, 3rd panel). Conversely, Mfge8 expression was completely absent 
from WT→ Mfge8-/- chimeras (Fig. 6.13 4th panel). These results indicate that only 
Figure 6.14. Mfge8+ cells do not 
express MOMA1 or ER-TR9.  
Cryosections of WT spleens were 
immunostained with 2422 
antibodies (green) and anti-
MOMA1 (left panel) or anti-ER-
TR9 antibodies (right panel). 
2422+ cells (green) residing at the 
border of the marginal zone were 
not positive for MOMA1 or ER-
TR9 (both red). These cells are 
therefore neither MOMA1+ 
metallophilic nor ER-TR9+ 
marginal zone macrophages. 
White squares outline the area 
shown in higher magnification. 
Scale bar upper panel: 100 μm, 
lower panel: 20 μm. 
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radiation resistant cells, such as FDCs, but not radiation sensitive cells, such as 
TBMφs, are the source of Mfge8 in the spleen.  
To exclude that the Mfge8+ cells encircling the follicle around the marginal zone are 
either ER-TR9+ marginal zone macrophages or MOMA1+ metallophilic macrophages 
dual-color IF was performed with anti-Mfge8 antibodies (green) together with either 
anti-ER-TR9 or anti-MOMA-1 antibodies (both red). Mfge8+ cells in the marginal zone 
did not colocalize with ER-TR9+ or with MOMA-1+ macrophages and are therefore a 
different cell population (Fig. 6.14). 
To deternibe whether in other lymphoid tissues Mfge8 expression is also exclusively 
stromal, inguinal lymph nodes from BM-chimeric mice were analysed by ISH (Fig. 
6.15). The results obtained from the lymph nodes coincided with the results observed 
in the spleen. All detectable Mfge8 originated from stromal cells, since only in 
inguinal lymph nodes from Mfge8-/-→WT an Mfge8 specific signal was detected  by 
ISH. In lymph nodes obtained from WT→ Mfge8-/- chimeras no Mfge8 expression was 
found (Fig. 6.15) 
To further corroborate the above findings, fluorescent ISH for Mfge8 in combination 
with IF for CD68 was performed. This method allows to directly visualize whether 
CD68+ TBMφs contain Mfge8 RNA. For this, splenic cryosection of previously 
immunized WT mice were prestained with a biotinylated anti-CD68 antibody before 
the same section was hybridized with the Mfge8 riboprobe. Analyses of the follicles 
clearly showed that none of the observed CD68+ cells contained
Figure 6.15. Analysis of 
Mfge8 expression in inguinal 
lymph nodes by ISH. 
Mfge8 expression in inguinal 
lymph nodes from WT→Mfge8-/- 
and Mfge8-/-→WT mice was 
assessed using ISH (left 
column). Adjacent sections 
were counterstained with H&E 
(right column). Mfge8 ex-
pression was only detectable 
when stromal cells were of WT 
origin. The observed 
background signal in the 
WT→Mfge8-/- lymph node 
orginates from co-isolated fat 
tissue and does not represent 
Mfge8 RNA expression. Scale 
bar: 200 μm. 
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Mfge8 RNA (Fig. 6.16, upper panel, white arrows). Consequently, non of the cells 
expressing Mfge8 RNA were CD68+ (Fig. 6.16, upper panel, yellow arrows). No 
Mfge8 specific signals could be detected in the Mfge8-/- spleen confirming the 
specificity of the riboprobe (Fig. 6.16 lower panel). 
Figure 6.16 CD68+ TBMφs lack Mfge8 RNA. 
Cryosections from WT and Mfge8-/- spleens were first immunolabeled with biotinylated CD68 
antibody (red) and then subsequently subjected to fluorescent ISH using an Mfge8-specific RNA 
probe (green). Yellow arrows indicate Mfge8 positive cells; white arrows indicate CD68+ cells. The 
green Mfge8 RNA specific signal failed to colocalize with CD68+ TBMφs. White squares outline the 
area shown in higher magnification. Scale bar in 1st column is 100 μm and in columns 2-4, 20 μm. 
To confirm the ISH results with a more sensitive method to exclude that TBMφs 
express Mfge8 at low levels, Mfge8 expression in the chimeric mice was determined 
by RT-PCR on cDNA synthesized from RNA isolated from splenocytes. In 
WT→Mfge8-/- chimeric spleens Mfge8 expression was below the detection limit of 
RT-PCR (<0.25% WT splenocyte RNA spiked into Mfge8-/- splenocyte RNA, data not 
shown), whereas Mfge8-/-→WT spleens showed expression levels similar to 
WT→WT spleens (Fig. 6.17). Therefore, >99.75% of Mfge8 mRNA in chimeric 
spleens originated from radiation resistant cells. Since RT-PCR is highly sensitive, 
these results strongly suggest that radiation resistant stromal cells are the only 
source of Mfge8 in the spleen. 
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Figure 6.17 RT-PCR analysis of chimeric mice. 
PCR (40 cycles) with Mfge8-specific primers was performed on cDNA from splenocytes from two 
different mice per group. In spleen Mfge8 expression was only observed in WT mice that 
received either WT or Mfge8-/- BM. No Mfge8 expression was found in Mfge8-/- mice that 
received WT BM or Mfge8-/- BM. Therefore only the stromal non-hematopoietic compartment 
showed Mfge8 expression. 
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6.3 Does restriction of Mfge8-deficiency to FDCs suffice to impair phagocytosis 
and cause SLE? 
6.3.1 Lack of Mfge8 expression by FDCs results in splenomegaly and increased 
binding of apoptotic cells by TBMφs  
Mfge8-/- mice have splenomegaly and exhibit a phagocytosis defect of TBMφs and 
develop SLE resulting in glomerulonephritis (Hanayama et al., 2004b). To answer 
which of these phenotypes are caused by the lack of Mfge8 expression by FDCs 
and/or other stromal cells, the different BM-chimeras where analyzed.  
The splenomegaly in aged mice could clearly be ascribed to lack of Mfge8 
expression by stromal cells. Only Mfge8-/-→Mfge8-/- and WT→Mfge8-/- mice with 
spleen weights of 125.7 mg ± 24.14 and 130.5 mg ± 16.44, respectively, developed 
splenomegaly. WT→WT and Mfge8-/-→WT mice had normal spleen sizes with 
weights of 66.73 mg ± 5.22 and 67.9 mg ± 7.6, respectively. Therefore, 
hematopoietic Mfge8 did not influence the spleen size (Fig. 6.18). 
 
Hanayama et al. showed, that TBMφs in Mfge8-/- mice were enlarged. This was 
caused by an accumulation of apoptotic cells on the macrophage´s surface due to 
impaired engulfment of apoptotic cells. To assess whether the phagocytosis defect of 
TBMφs can be attributed to the absence of FDC-produced Mfge8, the number of 
TUNEL+ cells per TBMφ was determined in the BM-chimeras. To this end, TUNEL 
assays combined with immunofluorescent stainings for CD68 were performed on 
spleens from previously immunized chimeric mice. All TUNEL+ cells associated with 
Figure 6.18 Stromal Mfge8-
deficiency causes splenomegaly. 
Spleen weights of BM-chimeric mice 
were determined 41 weeks post BM-
reconstitution after repeated 
immunization with OVA in alum. 
Mfge8-/-→Mfge8-/- and WT→Mfge8-/- 
mice showed markedly increased 
spleen weights compared to 
WT→WT and Mfge8-/-→WT mice. 
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CD68+ TBMφs residing within splenic follicles were counted and the average number 
of TUNEL+ cells per TBMφ was determined. TBMφs of Mfge8-/-→Mfge8-/- mice bound 
in average 2.55 ± 0.15 TUNEL+ cells, while TBMφs of WT→WT mice bound 2.00 ± 
0.17. TBMφs of WT→Mfge8-/- mice bound slightly more TUNEL+ cells (2.35 ± 0.18) 
than TBMφs of Mfge8-/-→WT mice (2.14 ± 0.11) (Fig. 6.19). TBMφs of non-
reconstituted WT mice bound 1.92 ± 0.45 and of non-reconstituted Mfge8-/- mice 2.51 
± 0.71 TUNEL+ cells. Although the observed differences were minor, there was a 
clear trend towards an increased number of bound TUNEL+ cells in the absence of 
Mfge8 on stromal cells, which supports the idea that FDC-derived Mfge8 is involved 
in controlling the engulfment of apoptotic cells. One explanation for the rather small 
differences could be the time point of analysis. The GC reaction is a very dynamic 
process and therefore the time point of analysis might be crucial. Furthermore, the 
fact that the mice analyzed were irradiated and reconstituted might also influence the 
kinetics of the GC reaction and might introduce further unknown parameters 
influencing the results.  
Figure 6.19 Lack of Mfge8 expression by FDCs results in increased binding of apoptotic cells 
by TBMφs. 
9 weeks after BM-reconstitution (after previous immunization with OVA in alum 6 and 8 weeks after 
BM-reconstitution) apoptotic cells were visualized by TUNEL assay on splenic cryosections. A CD68-
staining was included to visualize TBMφs. >300 TUNEL+ cells per group were counted and the 
average number of TUNEL+ cells per TBMφs determined. Mfge8-/-→Mfge8-/- and WT→Mfge8-/- showed 
a slightly higher number of TUNEL+ cells per TBMφ than WT→WT and Mfge8-/-→WT mice. For control 
unreconstituted WT and Mfge8-/- mice were included. 
Hanayama et al., showed by EM that apoptotic cells attached to the TBMφs were not 
engulfed. To determine whether this observation can be reproduced in BM-chimeric 
mice, 40 weeks after BM-transfer spleens from mice that were immunized several 
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times with OVA in alum were prepared for EM-analysis. In every case (WT→WT, 
Mfge8-/-→Mfge8-/-, Mfge8-/-→WT, and WT→Mfge8-/-) TBMφs with incorporated 
lymphocytes at different stages of degradation were found. (Fig. 6.20). These results 
strongly suggest, that even in the complete absence of Mfge8 TBMφs still have the 
ability to take up and degrade apoptotic cells. Therefore, several redundant 
mechanisms might exist that ensure the removal of apoptotic cells from the GC.  
Figure 6.20 Morphological features 
of TBMφs of aged BM-chimeric mice. 
40 weeks after reconstitution BM-
chimeric mice were analyzed by EM. In 
all chimeric mice (WT→WT, 
Mfge8-/-→Mfge8-/-, Mfge8-/-→WT, and 
WT→Mfge8-/-) apoptotic cells in 
different degradation stages were 
observed inside TBMφs indicating a 
general ability of TBMφs to 
phagocytose dying cells also in the 
absence of Mfge8. 
 
6.3.2 No proof of SLE can be found in BM-chimeras 
The SLE described in Mfge8-/- mice was characterized by glomerulonephritis with Ig-
deposits in the glomeruli and increased levels of ANA and anti-dsDNA antibodies at 
40 weeks of age or at young age after previous immunization (Hanayama et al., 
2004b). To assess whether the development of SLE can be attributed to a single 
compartment (stromal or hematopoietic) serum of the BM-chimeric mice was 
analyzed for elevated levels of autoantibodies by ELISA. To accelerate the onset of 
disease, BM-chimeric mice received three immunizations with OVA in alum in two 
week intervals starting 30 weeks after the BM-transfer. 41 weeks after the BM-
transfer serum was taken and the titre of dsDNA and ANA antibodies determined by 
ELISA. (Fig. 6.21). 
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Surprisingly, no differences between the different BM-chimeric mice were detected, 
no matter whether the stromal, the hematopoietic or both compartments lacked 
Mfge8 expression. Even the antibody levels of non-reconstituted Mfge8-/- mice did not 
show an elevation (Fig. 6.20).  
Figure 6.21 Determination of autoantibody titres. 
ANA and dsDNA antibody levels were determined by ELISI in serum from unreconstituted WT and 
Mfge8-/- mice and from WT→WT, Mfge8-/-→Mfge8-/-, Mfge8-/-→WT, and WT→Mfge8-/- BM-chimeric 
mice 41 weeks after BM-transfer. All mice showed similar levels of autoantibodies. N=3-6 mice per 
group. Each symbol represents one mouse.
Despite the absence of elevated autoantibody-levels, the kidneys of these mice were 
analyzed for pathologic alteratiions with periodic acid Schiff (PAS) staining. PAS 
staining visualizes glycogen and other polysaccharides which are present in basal 
membranes. This technique enables to detected pathologic alterations of the basal 
membranes of mesangial cells. Unfortunately, the BM-chimeras turned out to be not 
useful to determine the contribution of FDCs to SLE, because mice of all groups 
(WT→WT, Mfge8-/-→Mfge8-/-, Mfge8-/-→WT and WT→Mfge8-/-) developed a 
glomerulopathy with signs of mesangial lysis and some dispersed foamy cells, which 
are typical of a “radiation nephritis” caused by the lethal irradiation prior to the BM-
transfer (Fig. 6.22). Because the radiation-induced nephritis overshadowed the 
glomerulonephritis of Mfge8-/- mice, it was not possible to determine the contribution 
of either the stromal or hematopoietic compartment to the autoimmune 
glomerulonephritis. 
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 Figure 6.22 PAS staings of kidneys. 
PAS stainings were performed on paraffin-sections of kidneys from WT→WT, Mfge8-/-→Mfge8-/-, 
Mfge8-/-→WT, and WT→Mfge8-/- mice 41 weeks after the BM-transfer. All mice showed signs 
typical of a “radiation nephritis” with mesangial lysis and foamy cells within the glomeruli. Scale 
bar: 50 μm. 
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6.4 Putative FDC precursors express Mfge8 
6.4.1 Mfge8+ cells are present in spleens of Ltbr-/- and Rag1-/- mice 
The Mfge8 ISH detected not only mature FDC networks, but also scattered Mfge8+ 
cells within the follicle and Mfge8+ cells lining the marginal sinus (Fig. 6.13). Since up 
to date no FDC precursor cell has been identified, it is possible that these cells might 
represent immature FDC precursor cells. In order to assess, whether Mfge8 ISH 
hybridization can serve as a tool to detect putative FDC precursors, Ltbr-/- and Rag1-/- 
mice that were reported to lack mature FDCs due to the absence of LTβR-signaling 
or due to the lack of B cells providing LT, respectively were analyzed by Mfge8 ISH. 
Indeed, on splenic cryosections of Ltbr-/- few Mfge8+ were detectable. These cells 
were rare, but were localized inside splenic follicles and might represent a vey early 
FDC precursor cell that was arrested in its development due to the absence of LTβR-
Surprisingly, Rag1
signaling. (Fig 6.23, upper panel). 
 very abundant Mfge8 expression. These mice 
and therefore enabling differentiation to a more advanced stage.  
-/- mice showed
Figure 6.23 Mfge8+ cells in 
spleens of Ltbr-/- and Rag1-/- 
mice. 
Splenic cryosections of Ltbr-/- 
and Rag1-/- mice were stained 
with an Mfge8 riboprobe or 
with H&E. Both, in spleens of 
Ltbr-/- and Rag1-/- mice Mfge8+ 
cells were detected by ISH. 
While only few scattered 
Mfge8+ cells were present 
within follicles of Ltbr-/- mice, 
Rag1-/- mice showed 
abundant expression of Mfge8 
in and around small follicle-
like structures. Scale bar: 100 
μm. 
exhibited rather small follicle-like structures that were surrounded by Mfge8+ cells. In 
addition, many Mfge8+ cells were also found within these small follicle-like structures 
(Fig. 6.23 lower panel). These cells might represent a more advanced stage of FDC-
precursor cells. Since Rag1-/- mice still have LTα and LTβ expression by natural killer 
(NK) cells, it is plausible that NK cells can provide LTα and LTβ to FDC precursors 
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6.5 Regulation of Mfge8 expression in macrophages 
6.5.1 Thioglycollate induces Mfge8 expression in macrophages 
fge8 upon stimulation with 
is. To confirm that 
the Mfge8 expression in the peritoneum really originates from hematopietic cells, the 
In
e  suffering from severe pulmonitis was 
analyzed. While lungs from healthy mice lacked all detectable Mfge8 expression (Fig. 
Peritoneal Mφs were previously shown to express M
thioglycollate (Hanayama et al., 2002), which induces a peritonit
BM-chimeric mice were stimulated with thioglycollate for 48h. Then peritoneal Mφs 
were harvested by peritoneal lavage. RNA was isolated, cDNA synthesized and 
Mfge8 expression was analyzed by RT-PCR. In contrary to the observation in the 
spleen, Mfge8 expression in the peritoneum originated solely from hematopoietic 
cells. Mfge8 expression was only detectable in peritoneal lavage of WT→WT and 
WT→Mfge8-/- chimeras, but not in that of Mfge8-/-→WT and Mfge8-/-→Mfge8-/- 
chimeras (Fig. 6.24A). Furthermore, Mfge8 expression was only detectable upon 
stimulation with thioglycollate (Fig. 6.24B) and was absent in unstimulated cells. 
These results are in agreement with previous reports (Hanayama et al., 2002), and 
suggest that Mφs do not express Mfge8 under normal conditions, but only after 
stimulation.  
 line with this are results obtained from a 
xpression. In this screen a lung of a mouse
Figure 6.24 Mfge8 expression in macrophages. 
(A) PCR for Mfge8 on cDNA from thioglycollate 
elicited peritoneal Mφs showed the opposite 
expression pattern to the spleen: Mfge8 expression 
 was only found after reconstitution with WT BM
(upper panel). All Mfge8 expression originated from 
hematopoietic cells (B) PCR on cDNA derived from 
peritoneal Mφs without previous thioglycollate 
stimulation showed absence of Mfge8 expression in 
these cells (lower panel).  
screen of several tissues for Mfge8 
6.25, upper panel), this inflamed lung showed many large Mfge8 expressing cells 
(Fig. 6.25, middle panel). Staining of consecutive section with anti-CD68 antibodies 
suggested that Mfge8 expressing cells were alveolar Mφs (Fig. 25, middle panel). To 
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control for the specificity of the Mfge8 riboprobe Mfge8-/- lungs were included. There, 
no signal was detectable showing the specificity of the Mfge8 ISH (Fig. 6.25, lower 
panel). 
 
 
 
 
 
ssical, innate or alternative pathway, respectively. In contrast to 
 
Figure 6.25 Mfge8 expression in the lung. 
sections of lung tissue were subjected to ISH with an Mfge8 riboprobe (left colu
secutive sections were stained with H&E (middle column) or anti-CD68 antibodies
n). No Mfge8 expression was found in healthy WT lungs (upper panel) or in Mfge8-/-
 inflamed lung containing many large alveolar Mφs showed strong Mfge8 expressi
Cryo mn). 
Con  (right 
colum  lungs. 
Only an on. 
Scale bar: 200 μm. 
To gain deeper insight into the stimuli required to induce Mfge8 expression, isolated
eritoneal Mφ were stimulated with IFNγ and LPS, LPS alone or IL-4, common
ducers of the cla
p
in
classically activated Mφ, via IL-4 alternatively activated Mφ participate in an anti-
inflammatory response, which is associated with increased phagocytosis and antigen 
presentation (Stein et al., 1992, Goerdt and Orfanos, 1999). Mfge8 expression was 
quantified by RT-PCR after 24h of stimulation. Culturing of Mφs for 24h without 
stimulation already induced Mfge8 expression. But treatment with IFNγ and LPS or 
LPS alone almost completely shut off Mfge8 expression. IL-4 treatment, however 
increased Mfge8 expression 2.6 fold (Fig. 6.26). These results show that Mfge8 
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expression in Mφs is tightly regulated, whereas FDCs seem to express Mfge8 in a 
constitutive manner, since also putative FDC precursors express Mfge8 (Fig 6.23) 
and also naïve, non-immunized mice have Mfge8 expressing FDC networks. The 
results presented above indicate that TBMφs do not express Mfge8 under 
physiological conditions, not even after thorough immunization when many TBMφs 
show high immunoreactivity for Mfge8 antibodies.  
 
 
Figure 6.26 IL-4 induces Mfge8 
expression in Mφs. 
Isolated peritoneal Mφs were stimulated 
wit
Mfg
h LPS, LPS and IFNγ or IL-4 for 24h. 
e8 expression was quantified by RT-
 
PCR. After treatment with LPS Mfge8 
expression was reduced by 96.6% 
compared to untreated cells. After 
treatment with LPS and IFNγ Mfge8 
expression was reduced by 94.0%. 
Treatment with IL-4 resulted in a 2.6 fold 
higher Mfge8 expression than in untreated 
cells. Graph shows average ± SD Mfge8 
expression in relation to cultured, 
unstimulated Mφs from three 
independently performed experiments. 
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6.6 Mfge8 is dispensable for prion replication by FDCs 
6.6.1 Mfge8-/- mice show accelerated disease progression  
The initial aim of the microarray screen performed by Huber et al. (Huber et al., 2005) 
was not only to identify FDC specific genes, but also to identify genes expressed by 
FDCs that are involved in the replication or accumulation of prions. Mfge8 was an 
interesting candidate for being involved in prion diseases, due to the well established 
role of Mfge8 in the removal of apoptotic cells: It was interesting to determine 
whether Mfge8 is also capable to regulate the removal of prions. To address this 
question Mfge8-/- and WT mice on a (B6x129sv)F1 background were inoculated 
intraperitoneally (i.p.) and intracerebrally (i.c.) with prion. The disease progression 
until terminal stage was monitored and indeed differences in incubation times 
between controls and Mfge8-/- mice were found (Fig. 6.27). 
 Figure 6.27 Mfge8-/- show accelerated disease progression. 
WT (B6x129sv)F1 and Mfge8-/- were inoculated i.c. with 3logLD50 (n=4) and i.p. with 6log 
LD50 (n=6) and 3logLD50 (n=6) of RML6 prions. The incubation time until terminal 
disease was monitored. The mean incubation time after low dose (3logLD50) i.c. 
inoculation was drastically accelerated in Mfge8-/- mice (157.5 ± 1 in Mfge8-/- and 200.3 ± 
3.9 in WT mice). The differences in incubation time after low dose i.p. inoculation were 
minor (213.2 ± 19.4 in Mfge8-/- and 229.4 ± 9.6 in WT mice). After high dose (6logLD50) 
i.p. inoculation the differences were still less pronounced as after i.c. inoculation (195.2 ± 
7.9 in Mfge8-/- and 218.4 ± 2.2 in WT mice). 
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After low dose (3logLD50) i.c. inoculations the difference in incubation time was most 
pronounced. Mfge8-/- mice succumbed to disease approx. 43 days earlier than the 
WT controls. After i.p. inoculation the differences were much less distinct (approx. 16 
days after low dose and approx. 23 days after high dose inoculation). Since the 
differences were most pronounced after i.c. inoculation, where the infectious agent is 
directly admitted to the CNS, without requiring prior replication in lymphoid organs, it 
is unlikely that Mfge8 deficiency in FDCs accounted for this effect. To further confirm 
this notion, accumulation of disease-associated proteinase K (PK) resistant PrPSc 
was visualized by histoblot. No obvious differences between Mfge8-/- mice and 
controls in accumulation of PrPSc by FDCs could be observed by this technique (Fig. 
6.28A). Also quantification of PrPSc by densitometry on Western blots of PK-treated 
spleen homogenates did not reveal any significant differences in the amount of PrPSc 
(Fig.6.28B). Hence, it seems unlikely that Mfge8 produced by FDCs influences either 
the degradation or the replication of prions. 
Figure 6.28 PrPSc accumulation in the spleen. 
(A) Histoblots of spleens from high and low dose i.p. inoculated Mfge8-/- and WT mice showed 
accumulation of PK-resistant PrPSc on FDCs. No differences in the depostition of PrPSc could be 
observed between WT and Mfge8-/- mice. (B) PrPSc was quantified by densitometry on Western 
blots from PK-treated spleen homogenates from high and low dose inoculated WT and Mfge8-/- 
mice. Also there no significant differences were detected. N = 5 mice per group. 
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The most striking difference in incubation time was found after i.c inoculation. 
Therefore, it is likely that Mfge8 deficiency alters prion replication or degradation in 
the CNS. This question was addressed by IHC for PrPSc aggregates using the anti-
PrP antibody SAF84 and by Western blotting of brain tissue (Fig. 6.29). 
Immunohistochemistry using SAF84 and quantitation of PrPSc by Western blotting 
and densitometry revealed significantly increased levels of PrPSc in brains of Mfge8-/- 
mice, providing first evidence that Mfge8 might be involved in clearing prions from the 
brain (Fig. 6.29A and 6.29B). To ensure that this increase in PrPSc levels is not 
merely due to elevated levels of PrPC, its levels were also quantified by Western blot. 
However, no significant difference between WT and Mfge8-/- mice was detectable 
(Fig. 6.29C), confirming a true increase in PrPSc levels. Consequently, Mfge8-/- 
accumulate more PrPSc within shorter time, since they succumb to disease more than 
40 days earlier. 
To see whether the increased PrPSc levels also manifest in more severe brain 
damage, the degree of spongiosis, astrogliosis and microgliosis was analyzed by 
H&E, GFAP and IBA1 stainings, respectively. However, there the severity of the 
spongiosis as well of the astrogliosis and the microgliosis was unaltered between WT 
and Mfge8-/- mice, but both groups showed extensive spongiosis and activation of 
astrocytes and microglia in the brain (Fig. 6.30). Apart from increased levels of PrPSc 
in the brains of Mfge8-/- mice no alterations in prion pathogenesis could be found. 
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 Figure 6.29 Increased PrPSc levels in the brain of Mfge8-/- mice. 
(A) Stainings of brain section with the anti-PrP antibody SAF84 revealed increased 
deposition of PrPSc in the brains of Mfge8-/- mice. (B) Western blotting of brain homogenates 
from terminal i.c. inoculated WT and Mfge8-/- mice without (upper blot) and with PK (lower 
blot) shows increased levels of PrP
 
 
P
Sc. Quantitation by densitometry shows a siginificant 
increase of PrPSc 
 
P  of about 50%. (C) Western blotting of healthy WT and Mfge8-/- brain 
homogenates using anti-PrP antibodies with subsequent quantitation by densitometry 
showed that PrPC levels were not different between WT and Mfge8-/- mice.  
Graphs show average relative signal intensity, error bars represent the SD, n=4 (B) and n=3 
(C). For statistical analysis Student´s T test was used. 
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Figure 6.30 Histopathological 
analysis of terminal Mfge8-/- brains. 
Spongiform changes were analyzed on 
brain sections from terminal WT and 
Mfge8-/- mice by H&E staining. No 
difference between WT and Mfge8-/- 
brains was observed. Astrogliosis was 
analyzed by GFAP staining (middle 
panel) and microgliosis by IBA1 staining 
(lower panel). Also there was no 
obvious difference between WT and 
Mfge8-/- mice. 
6.6.2 Analysis of Mfge8 expression in the brain 
Since it was unknown whether Mfge8 is expressed in the brain, different brain 
derived cells were analyzed by qPCR for Mfge8 expression. Furthermore, the Mfge8 
expression pattern was determined by ISH on brain tissue (Fig. 6.31). Cultured 
astrocytes showed the highest Mfge8 expression by quantitative qPCR. Only minimal 
Mfge8 expression was detected by cultured neurons, oligodendrocytes or microglia 
(Fig. 6.31A). Either these cell types express Mfge8 to very low levels, or the residual 
Mfge8 expression originates from contaminating astroctyes. 
ISH revealed a scattered Mfge8 expression pattern in cortical brain areas. These 
cells might be astrocytes, since primary astrocyte-cultures showed abundant Mfge8 
expression by qPCR. But to determine the identity of these cells beyond any doubt 
further characterization needs to be performed. Also in the cerebellum Mfge8+ cells 
were detected. These cells were located close to Purkinje neurons and most likely 
represent Bergman glia (Fig. 6.31B).  
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Figure 6.31 Mfge8 expression 
analysis in the brain. 
(A) Expression of Mfge8 in 
cultured astrocytes, microglia, 
oligodendrocytes and neurons 
was quantified by qPCR.  Only 
astrocytes showed abundant 
Mfge8 expression. Error bar 
represent SD, n=3 indepent 
cultures per group. (B) ISH for 
Mfge8 on brain cryosection. 
Mfge8+ cells in the cortex might 
resemble astroglia. In the 
cerebellum Mfge8 expression 
was found in Bergman glia. 
Scale bar 100 μm. 
6.6.3 Influence of Mfge8 on prion pathogenesis is dependent on the genetic 
background 
The Mfge8-/- mice used for the prion inoculation study where made in the R1 ES cell 
line, which was established from a (129X1/SvJ x 129S1)F1 3.5-day blastocyst (Nagy 
et al., 1993). The obtained founder was crossed once time with a C57BL/6 female. 
The resulting F1 generation was intercrossed with each other. Therefore, the mice 
used for this study were on a mixed B6x129 background. Unfortunately, many 
different sublines of the 129 background exist. Thus, it is almost impossible to find 
control mice that closely match the genetic background of the Mfge8-/- mice. Here, 
129sv mice obtained from Charles River Laboratories were intercrossed with 
C57BL/6 mice. The F1 generation resulting from this intercrossing served as WT 
controls for the inoculation study, though the genetic backgrounds between controls 
and Mfge8-/- were only roughly matched. This fact raised some concerns that the 
accelerated prion pathogenesis in the Mfge8-/- might be an artefact caused by 
comparing them to mice of a different genetic background. To address these 
concerns, the inoculation study was repeated with Mfge8-/- mice which were 
backcrossed onto the C57BL/6 background for ten generations (B6-Mfge8-/-) when 
these mice became available. For i.c. inoculation with a low dose of prions littermates 
that were either Mfge8-/-, Mfge8+/- or Mfge8+/+ were used. Surprisingly, there was no 
difference in incubation time between the three groups. The mean incubation time of 
all groups was around 180 days (Fig. 6.32A). To determine whether the B6-Mfge8-/- 
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mice still exhibit increased levels of PrPSc in their brains at terminal stage, the PrPSc 
content was analyzed by Western blot. To this end, brain homogenates from terminal 
B6-Mfge8+/+ and B6-Mfge8-/- mice were compared against each other. The PrPSc 
content showed strong variations between the individual mice, but over all there was 
no clear difference between the PrPSc levels of B6-Mfge8+/+ and B6-Mfge8-/- mice. 
These results suggest that the phenotype observed in the mixed background Mfge8-/- 
mice is either an artefact caused by comparison of mice on a very different genetic 
background or is a real Mfge8-dependent effect, that only manifests on a certain 
genetic background. This question will be addressed in the future. 
 
Figure 6.32 Inoculation of B6-Mfge8-/- mice. 
(A) B6-Mfge8+/+, B6-Mfge8+/- and B6-Mfge8-/- littermates were inoculated i.c. with 3logLD50 (n=7) of 
RML6 prions. The incubation time until terminal disease was monitored. The mean incubation times 
were 183.5 ± 9.1 in B6-Mfge8+/+, 183.6 ± 9.1 in B6-Mfge8+/- and 186.3 ± 3.1 in B6-Mfge8-/- mice. (B) 
PrP-Western blotting of brain homogenates from terminal i.c. inoculated B6-Mfge8+/+ (n=8) and B6-
Mfge8-/- (n=7) mice after PK-digestion showed varying levels of PrPSc between individual mice, but no 
general increase in B6-Mfge8-/- mice. 
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7 Discussion 
7.1 Identification of FDC-M1 as Mfge8 provides a new tool to study FDCs 
The murine FDC-marker FDC-M1 is currently the most specific marker used to 
characterize FDCs. However, since the nature of the antigen was unknown, the 
scope of this marker was limited to histological studies of FDCs. This study identified 
FDC-M1 as Mfge8 by IF competition experiments (Fig. 6.3, 6.5 and 6.6), surface 
plasmon resonance (Fig. 6.7) and immunoprecipitation (Fig. 6.8). 
The identification of the gene that encodes for FDC-M1 as Mfge8 broadens the 
spectrum of techniques that can be used to analyze FDCs. Several new antibodies 
are now available, such as the anti-Mfge8 antibody clone 18A2-G10 which allows 
detection of FDC-M1/Mfge8 on formalin-fixed archived tissue (not shown) and in 
Western blot (Fig. 6.8), which was not possible with the anti-FDC-M1 antibody 4C11. 
Furthermore, the discovery that Mfge8 is exclusively expressed by FDCs and few 
other stromal cells, that might represent FDC precursors, enables characterization of 
FDCs on RNA level. Quantitative studies are now possible using qPCR with Mfge8-
specific primers. Also ISH with an Mfge8 riboprobe will be a useful tool for histological 
studies of FDCs, especially since the Mfge8 ISH proved to be more sensitive than the 
FDC-M1 IHC. The Mfge8 ISH even detected Mfge8+ cells in Ltβr/- and Rag1-/- mice 
(Fig.6.23), where mature FDCs are absent. It will be very interesting to study whether 
these cells are indeed FDC precursors that are arrested in a premature stage due to 
impaired LTβR-signaling.  
Since the Mfge8 ISH was able to detect putative FDC precursors in a very early 
developmental stage this method might enable to follow FDC-maturation from early 
postnatal stages until first mature FDCs occur. If this leads to the discovery of an 
FDC-stem cell, the long-standing question of where FDCs come from and whether 
they are of stromal or hematopoietic origin might finally be answered. 
The unexpected finding that Mfge8 is already expressed in putative FDC precursors 
might hint to an additional function of Mfge8 in the spleen. Indeed, a role of Mfge8 in 
angiogenesis has been described and it might also be interesting to investigate 
whether Mfge8 produced by FDCs and their putative precursors are involved in the 
vascularization of the spleen and lymph nodes. 
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7.2 FDCs and not TBMφs produce Mfge8 in the spleen 
In 2004 Hanayama et al. published that Mfge8 is exclusively produced by TBMφs in 
the spleen. Data from the study presented here and also other studies contradict this 
view. Huber et al. showed that Mfge8 expression is increased in FDC-enriched 
versus FDC-depleted fractions. This was the first indication that also FDCs express 
Mfge8, but from this study it could not be excluded that TBMφs are co-enriched 
together with the FDCs resulting in the observed increase in Mfge8 expression. 
However, first Mfge8 ISH results presented by Huber et al., suggested that TBMφs 
cannot be the only source in the spleen (Huber et al., 2005).  
In the current study the source of Mfge8 expression was analyzed in detail. The fact 
that IF using anti-Mfge8 antibodies clearly stained FDC-networks and that the FDC-
marker FDC-M1 was identified as Mfge8 gave strong support that FDCs indeed 
produce Mfge8. But to finally determine the source of Mfge8, Mfge8 expression had 
to be analyzed on protein and RNA level by ISH in reciprocal BM-chimeras of WT 
and Mfge8-/- mice. Since FDCs are radiation resistant and TBMφs radiation sensitive 
BM-chimeras where an adequate tool to answer this question. The surprising result 
was that Mfge8 protein could only be detected in TBMφs when the stromal 
compartment was of WT origin, even with TBMφs clearly being of Mfge8-/- origin (Fig. 
6.12). These results illustrated first evidence that FDCs rather than TBMφs are the 
actual source of Mfge8. This hypothesis was further corroborated by ISH analysis of 
the BM-chimeras. ISH and RT-PCR showed that all Mfge8 RNA was of stromal and 
not of hematopoietic origin. Also ISH combined with IF for CD68 on WT mice showed 
that CD68+ TBMφs did not contain any detectable Mfge8 RNA. Therefore, the idea 
how Mfge8 functions in the GC had to be revised. Not the macrophages license 
themselves to remove apoptotic B cells, but FDCs by providing Mfge8, which 
opsonizes apoptotic cells and then targets them for uptake by TBMφs. Hence, these 
results identified a novel function of FDCs: not only do they regulate the survival of 
GC B cells during a GC reaction, they also control their rapid removal after their 
death. This model would explain why TBMφs can be detected as Mfge8+ cells by IHC 
upon ingestion of Mfge8-decorated apoptotic B cells. This model requires that two 
distinct cell types, FDCs and TBMφs, collaborate in this removal process. This is 
plausible, because apoptosis is a rather frequent event in the GC, whereas TBMφs 
are a rather rare cell type, which might limit the removal process. But if the removal is 
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not rapid enough, then autoimmunity impends. To ensure efficient removal, TBMφs 
have to be guided specifically in a target-oriented manner to the apoptotic cell. This is 
best achieved by a local Mfge8-gradient produced by FDC that directs TBMφs to the 
apoptotic cells. Since FDCs and B cells are in intimate contact, dying B cells can 
already be decorated with Mfge8 while still in contact with FDCs. This two-tiered 
mechanism may help ensuring that two rather few cell types – FDCs and TBMφs -
efficiently recognize and degrade large numbers of apoptotic cells (Fig. 7.1B).  
 
Figure 7.1 Models of Mfge8-dependent removal of apoptotic cells from the GC. 
(A) Previous model of Mfge8-dependent engulfment of apoptotic cells. This model still holds true 
in acute inflammatory conditions, where macrophages are induced to express Mfge8 themselves. 
Macrophages secrete Mfge8 (2) which subsequently targets apoptotic B cells (2). This allows 
macrophages to bind Mfge8-opsonized apoptotic cells via integrins (3). The interaction of Mfge8 
with intregins induces the engulfment of the apoptotic cell (4). Adapted from Zullig and 
Hengartner, 2004.  
(B) Revised model of Mfge8-dependent engulfment of apoptotic cells. In the spleen, Mfge8 is not 
produced by macrophages, but by FDCs. They establish a local Mfge8-gradient with the highest 
Mfge8-concentration in the GC (1). Along this gradient unarmed, distant TBMφs are recruited 
directly to the location where apoptosis occurs (2). There, apoptotic cells become directly 
decorated with FDC-derived Mfge8 while still in contact with FDCs (3). Only proximal TBMφs 
become armed for engulfment of apoptotic B cells in an Mfge8-dependent manner (4). This target-
oriented two-tiered process allows two rare cell types to efficiently and rapidly remove apoptotic 
cells from the GC. 
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7.3 Complementary mechanism might control the removal of apoptotic cells 
from the GC 
The rapid removal of apoptotic cells from the GC is of great importance, since upon 
impairment of this process, unremoved cells become necrotic, which results in 
release of DNA and other nuclear components. This is believed to be a cause of 
SLE, an autoimmune disease where systemic autoantibodies target nuclear 
components resulting in extensive tissue damage. Mfge8-/- mice were reported to 
develop SLE, though it appeared to be a rather mild form. They have a normal life 
span, increased levels of autoantibodies and glomerulonephritis that can only be 
observed at old age or after thorough immunization. 
So far, no connection of FDCs and SLE has been described. However the above 
findings suggest that not only impaired TBMφs function, but also impaired FDC 
function can cause SLE. Thus, the BM-chimeric mice were analyzed to determine 
whether stromal Mfge8-deficiency alone suffices to impair removal of apoptotic cells 
from the GC and to cause SLE. To this end, the amount of apoptotic cells associated 
with TBMφs was quantified and revealed a mild increase in the case of complete 
(non-reconstituted Mfge8-/- mice or Mfge8-/-→Mfge8-/- mice) or stromal (WT→Mfge8-/- 
mice) Mfge8-deficiency (Fig. 6.19). These results are in agreement with previous 
studies, although they seem to be less pronounced in the current study (Hanayama 
et al., 2004b). This observation can be interpreted as an impairment of the 
internalization and degradation of apoptotic cells. However, the EM analysis showed 
that even in the complete absence of Mfge8 (Mfge8-/-→Mfge8-/-) internalized 
lymphocytes in different degradation stages could be found within TBMφs. 
One possible explanation for this discrepancy is that several complementary 
mechanisms exist to ensure rapid removal of apoptotic cells. Plausible other 
candidates controlling the removal of apoptotic cells in the GC are complement 
factors which are known to target cells for phagocytosis. FDCs are a source of C1q 
and C1q-deficient mice also develop SLE (Schwaeble et al., 1995, Botto, 1998, 
Walport et al., 1998), underlining the importance of this cell type in regulating the 
removal of apoptotic cells in more than one way.  
Unfortunately, the BM-chimeric mice proved to be not useful to study the SLE-
induced glomerulonephritis, since all BM-chimeric mice developed a glomerulopathy 
due to the lethal irradiation which masked the autoimmune glomerulonephritis of 
Mfge8-/- mice (Fig. 6.22). The analysis of autoantibody levels did not yield evidence 
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supporting the presence of SLE in any of the analyzed mice, since autoantibody 
levels seemed unaltered in all chimeras (Fig. 6.21). Even in non-reconstituted mice 
no increased levels of autoantibodies could be detected. As mentioned above, the 
SLE in Mfge8-/- is rather mild and this might explain the difficulties in reproducing the 
elevated levels of autoantibodies. If the incidence of SLE in Mfge8-/- mice is low, 
development of SLE might depend on continous and extended stimulation with 
pathogens. Thus, the housing conditions and hygiene status of the mice might play 
an important role and could account for the differences between this study and 
previous reports. 
Nevertheless, the above described findings raise the possibility that impaired FDC 
function can actively contribute to the development of SLE. It might be interesting to 
see, whether mice deficient for both, Mfge8 and C1q exhibit a more dramatic SLE 
phenotype than knockout mice deficient of only one of these genes. 
 
7.4 Acute inflammation induces Mfge8 expression in macrophages 
Regulation of Mfge8 expression and of the removal of apoptotic cells seems to differ 
in organs other than the spleen During an acute inflammation, not stromal cells, but 
macrohages themselves produce Mfge8 (Fig. 6.24 and 6.25) (Hanayama et al., 
2002). FDCs are only restricted to lymphoid organs and Mfge8 expression has only 
been found in a few other stromal cells. But during acute inflammations, such as 
thioglycollate peritonitis or pulmonitis, extensive cell death occurs, hence Mfge8 
expression must be inducible throughout the whole body wherever extensive cell 
death requires it. This is best achieved by mobile cells that are efficiently recruited to 
the site of the inflammation during an immune response. Macrophages constitute 
such a cell type. However, Mfge8 expression in macrophages seems to be tightly 
regulated. Interestingly, IL-4, but not IFNγ or LPS induced Mfge8 expression. While 
IFNγ and LPS, inducers of the classical and innate macrophage-activation pathways 
promote an inflammatory response, IL-4, inducer of the alternative macrophage 
activation pathway, is thought to elicit an anti-inflammatory response. The anti-
inflammatory macrophage response is associated with phagocytosis and increased 
antigen-presentation (Stein et al., 1992, Goerdt and Orfanos, 1999). It would be 
interesting to study the consequences of Mfge8-deficiency on disease-severity or 
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pathogen-load in different inflammatory disease models with profound Mφ 
involvement. 
The observation that the anti-inflammatory cytokine IL-4 induces Mfge8 expression in 
Mφs raises the possibility that Mfge8 is directly involved in this anti-inflammatory 
reaction. If this was true, then Mfge8 produced by FDCs could participate in the 
control of cell activation in the GC. In Mfge8-/- mice GC cells could therefore be 
hyperactive and a downregulation of the GC reaction might be impaired. This could 
lead to stronger and extended GC reactions and might, apart from the phagocytosis 
defect, contribute to the SLE and the enlarged spleen sizes observed in Mfge8-/- 
mice. 
 
7.5 The role of Mfge8 in prion pathogenesis 
While FDCs are the most important cell type for prion replication in lymphoid organs, 
it remains unclear why FDCs are so efficient in replication and accumulation of 
prions. Since FDCs are high expressors of Mfge8,  the latter might have the potential 
to bind prions in order to target them for degradation by macrophages. To this end,  
Mfge8-/- mice were challenged with high and low doses of prions through the 
intraperitoneal (i.p.) and the intracerebral (i.c.) route.  
Mfge8-/- mice on a mixed (B6x129) background exhibited a mild disease-acceleration 
after i.p. and a drastic acceleration after i.c. inoculation of prions. This acceleration is 
unlikely to be caused by altered prion replication or accumulation on FDCs, because 
the acceleration was most pronounced after i.c. inoculation, where disease 
progression is independent of the immune system. Furthermore, PrPSc accumulation 
in the spleen seemed to be unaltered in Mfge8-/- mice as assessed by histoblot and 
Western blot. In the brain however, increased levels of PrPSc were observed by IHC 
and Western blot. These results imply an involvement of Mfge8 in prion 
pathogenesis. Due to the known function of Mfge8 in the regulation of phagocytosis, 
it is likely that Mfge8-deficiency impairs either degradation of prions directly or the 
removal of apoptotic prion-infected cells. Both scenarios could explain the increased 
PrPSc levels in the brain. 
The observed disease acceleration, however, seemed to be dependent on the 
genetic background of the mice. Mfge8-/- mice, that were backcrossed onto the 
C57BL/6 background for ten generations showed no alteration in prion pathogenesis. 
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Crossing the mixed background Mfge8-/- mice with the (B6x129) WT mice would help 
to exclude that the observed acceleration was an artefact caused by comparing 
incubation times of groups that differed too much in the genetic background. The 
resulting heterozygous F1 generation of this crossing has to be intercrossed and the 
disease progression of the Mfge8+/+, Mfge8+/- and Mfge8-/- littermates of the F2-
generation has to be compared. In addition to this, the Mfge8-/- mice could be 
crossed to another unrelated genetic background, like e.g. Balb/C. It would speak in 
favour for a true involvement of Mfge8 in prion pathogensis, if an acceleration can be 
observed in several very different genetic backgrounds or if a dose-dependent effect 
in Mfge8+/- mice can be observed 
A possible explanation for the dependence of the disease acceleration on the genetic 
background could be that complementary molecular pathways, differently regulated 
in mice of different backgrounds, exist. One potential candidate is DEL-1, which has 
been shown to be a functional homolog of Mfge8 (Hanayama et al., 2004a, 
Hanayama et al., 2006). Therefore, it might be revealing to analyze DEL-1 
expression in the brain of mice of different genetic backgrounds. 
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8 Materials and Methods 
8.1 Mice 
Mfge8-/- mice were generated in the lab of Shigekazu Nagata and were on a 
(C57BL/6x129)F1 mixed (Hanayama et al., 2004b) or C57BL/6 background. As 
controls C57BL/6 (Harlan Laboratories) or F1 offsprings of crossings between 
C57BL/6 and 129Sv mice (Charles River) were used. C57BL/6-CD45.1 mice were 
from Harlan Laboratories. All experiments were in accordance with Swiss federal 
legislation and had been approved by the local authorities. 
 
8.2 Antibodies, recombinant proteins and other reagents 
rEGF and rMfge8 were both from R&D Systems. rPrP was produced and purified as 
described (Zahn et al., 1997). 4C11 was from NovImmune SA, Geneva, Switzerland 
or from BD Pharmingen. Anti-Mfge8 clone 18A2-G10 was from MBL, International 
Corporation, and anti-Mfge8 clone 2422 from Alexis Biochemicals. Anti-CD21/35, 
FITC-labeled CD45.2, PE-labeled and biotinylated CD45.1 were from BD 
Pharmingen, biotinylated anti-CD68 clone FA-11, MOMA1 and rat IgG2c isotype 
control were from Serotec. ER-TR9 antibody was from Bachem AG, Switzerland. 
Anti-GFAP antibody was from DAKO, anti-IBA1 from Wako Chemicals and anti-PrP 
SAF84 antibody from SPI bio. Cy5-conjugated anti-PrP antibody POM2 was 
developed in house (Polymenidou et al., 2005). Secondary reagents were F(ab’)2 
goat anti-hamster IgG FITC-labeled from Serotec, Alexa Fluor 594 goat anti-rat IgG 
(H+L), Streptavidin Alexa Fluor 647 from Molecular Probes and goat anti-Armenian 
hamster IgG-HRP from Santa Cruz Biotechnology. For in vitro stimulation of 
peritoneal macrophages LPS from Salmonella abortus equi (BioClot), IFNγ from R&D 
Systems and IL-4 from Sigma were used. 
 
8.3 IHC, IF, TUNEL assay and competition with recombinant proteins 
IHC for hematoxylin/eosin, FDC-M1 (1:50), CD21/35 (1:100) and CD68 (1:100) for 
light microscopy was performed on acetone-fixed spleen cryoscetions (5-10 μm) 
Blocking was performed in PBS containing 1% goat serum and 0.5% BSA. For 
detection, alkaline phosphatase (AP) conjugated secondary affinity-purified 
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polyclonal anti-Ig antibodies were used. AP was visualized using naphthol AS-BI 
phosphate and New Fuchsin as substrate, which yields a red precipitate. 
Endogenous AP was blocked by levamisole. Sections were counterstained with 
hematoxilin.. 
IHC for GFAP (1:1000) and IBA1 (1:1000) was performed on paraffin sections and 
detected with diaminobenzidine (Sigma). For PrP staining, formalin-fixed brain tissue 
were treated with concentrated formic acid for 60 min to inactivate prion infectivity. 
Postfixation in formalin was performed for at least 1 d, and tissues were embedded in 
paraffin. After deparaffination, sections (1-2 μm) were incubated for 6 min in 98% 
formic acid and washed in distilled water for 30 min. Sections were heated to 100°C 
in a steamer in citrate buffer (pH 6.0) for 3 min, and allowed to cool down to room 
temperature. Sections were incubated in VENTANA buffer and stains were 
performed on a NEXEX IHC robot (VENTANA instruments) using an IVIEW DAB 
Detection Kit (VENTANA Instruments). After incubation with protease 1 (VENTANA) 
for 16 min, sections were incubated with anti-PrP SAF-84 (1:200) for 32 min. 
Sections were counterstained with hematoxylin.  
For IF, cyryosections were acetone-fixed and blocked (PBS containing 0.5% BSA 
and 1% goat serum), primary antibodies were added (2 μg/ml of 18A2-G10 and 2422 
and 1 μg/ml of FDC-M1 or biotinylated anti-CD68). For competition, 18A2-G10 or 
FDC-M1 were incubated with 10 or 25 μg/ml rMfge8, rEGF or rPrP (1 hr, RT) before 
applying onto the sections. After washing secondary antibodies were added and 
analyzed by fluorescence microscopy (BX61, Olympus). TUNEL stainings were 
performed with the ApopTaq Plus Fluorescein In Situ Apoptosis Detection Kit 
(Chemicon) according to the manufacturer’s instructions. Prior to TUNEL staining 
sections were fixed with 1% paraformaldehyde (PFA), washed, blocked and stained 
with biotinylated anti-CD68 (1 μg/ml) and postfixed again with PFA. 
 
8.4 Immunoprecipitation and Western blotting 
Paramagnetic beads (tosylactivated M280 Dynabeads, Dynal) were conjugated with 
purified 4C11, 2422 or rat IgG2c isotype control antibody according to the 
manufacturer’s manual. Protein concentrations of 10% homogenates from WT and 
Mfge8-/- spleens were determined by BCA (bicinchoninic acid) Protein Assays 
(Pierce), according to the manufacturer’s instructions. Homogenates were incubated 
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with 4C11-, 2422-, or IgG2c-beads, washed and resuspended in PBS containing 
sample buffer (NUPAGE® LDS Sample Buffer, Invitrogen) and subjected to Western 
blotting. Blots were blocked with 1x blocking buffer (Sigma) containing 1% goat 
serum and incubated with anti-Mfge8 antibody 18A2-G10 (0.5 μg/ml). For detection 
goat anti-Armenian hamster IgG-HRP (0.08 μg/ml) was used. After adding substrate 
(SuperSignal West Dura, Pierce) blots were analyzed with a FUJI LAS 3000 imaging 
system. 
For detection of PrPSc by Western blot 50 μg of brain or spleen tissue homogentates 
were treated with proteinase K (50 μg/ml for brain, 20 μg/ml for spleen, 30 min, 
37oC). Electrophoresis was done on 12% Bis-Tris NUPAGE gels (Invitrogen). 
Membranes were blocked (5% Topblock, Sigma) incubated with monoclonal antibody 
POM1 (1:10000) and detected with goat anti-mouse IgG1-HRP (1:10000), and 
visualized by enhanced chemiluminescence (ECL, Amersham). 
 
8.5 Surface plasmon resonance (SPR) experiments  
Surface plasmons are surface electromagnetic waves that propagate parallel along a 
metal interface. These waves oscillate at the boundary of the metal and the 
surrounding medium and are very sensitive to any changes of this boundary, such as 
the adsorption of molecules to the metal surface. Therefore, by recording changes in 
the electromagnetic waves using light beams that excite surface plasmons in a 
resonant manner, this technique can be used to measure interactions between 
molecules. 
All experiments were performed with Biacore 3000. Rat IgG2c isotype control and 
4C11 or 18A2-G10 antibodies were covalently captured on flow cells 1 and 2 
respectively of a CM5 chip (Biacore) after activation with NHS/EDC at a flow rate of 5 
μl/min. 5 μl of a 50 μg/ml antibody solution in acetate buffer (pH 4.5), were used to 
immobilize approx. 10’000 response units (RU) of covalently bound antibody. After 
surface inactivation with ethanolamine, the system was primed and a new sensogram 
was started with HBS-EP (Biacore) as running buffer. Similarly, approx. 15’000 RUs 
of each rPrP and rMfge8 were immobilized on the control and sample flow cell, 
respectively. 
50 μl were used for all injections at a constant flow rate at 5 μl/min. All recombinant 
proteins or antibodies were injected at a concentration of 50 μg/ml diluted in HBS-EP 
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buffer (Biacore). For control, all protein-injections were made on two flow cells, where 
the first flow cell was coated with control protein or antibody and the second with the 
protein/antibody of interest. Regeneration of chip surfaces was achieved by 100 mM 
HCl. All sensograms represent changes in RUs on the flow cell immobilized with 
sample antibody or protein, after subtraction of changes in RUs on control flow cells. 
 
8.6 Generation of BM chimeras and immunizations 
BM cells were isolated from tibiae and femurs of donor mice and injected i.v. into the 
tail vein of previously irradiated (950 rad) hosts. Each mouse received i.v. 1x107 
donor BM cells. Reconstitution efficiency was assed after 5 weeks by FACS-analysis 
of CD45.1 and CD45.2 expression of blood leukocytes. 6 weeks post engraftment 
mice were immunized i.p. with 100 μg OVA (Sigma) in alum (Imject Alum, Pierce). 2 
weeks later mice were boosted with the same dose of OVA in alum. 
 
8.7 RNA isolation and cDNA synthesis  
Total RNA from splenocytes or peritoneal macrophages was isolated using Trizol 
(Invitrogen). 1 μg RNA was used for cDNA synthesis. Prior to cDNA contaminating 
genomic DNA was removed. cDNA synthesis was done with QuantiTect Reverse 
Transcription Kit (Qiagen) according to the manufacturer’s instruction. cDNA 
synthesis was tested by performing PCR (40 cycles) with primers specific for Gapdh. 
All samples were validated free of contaminating genomic DNA. PCR was performed 
with 2x PCR Master Mix (Promega). 
 
8.8 quantitative Real Time PCR (QPCR) analysis and primers 
Quantitative real-time PCR was performed using SYBR Green PCR Master Mix 
(Qiagen AG, Switzerland) on a 7900HT Fast Real-Time PCR System (Applied 
Biosystems) using default cycling conditions. Expression levels were normalized 
using Gapdh.  
Gapdh forward primer: 5’-CCACCCCAGCAAGGAGACT-3’  
Gapdh reverse primer: 5’-GAAATTGTGAGGGAGATGCT-3’  
Mfge8 forward primer: 5’-ATATGGGTTTCATGGGCTTG-3’ 
Mfge8 reverse primer: 5’-GAGGCTGTAAGCCACCTTGA-3  
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Cxcl13 forward primer: 5’-TCGTGCCAAATGGTTACAAA-3’  
Cxcl13 reverse primer: 5’-ACA AGG ATG TGG GTT GGG TA-3’ 
Ptprc forward primer: 5’-AAA CGA TCG GTG ACT TTT GG -3’  
Ptprc reverse primer: 5’-AGC TCT TCC CCT TTC CAT GT-3’ 
8.9 FDC clusters isolation  
To isolate FDCs, lymph nodes of 5 previously immunized and irradiated mice were 
dissected and enzymatically digested as described previously (Sukumar et al., 2006). 
The suspended cells from the digested lymph nodes were collected by centrifugation 
and resuspended in PBS containing FCS. The cells were then incubated with 
biotinylated 4C11 and mouse FcR blocking antibody (StemCell Technologies). 
Positive selection of Mfge8+ cells was performed using the EasySep Biotin selection 
kit (StemCell Technologies). In brief, cells were incubated with EasySep Biotin 
selection cocktail. Then cells were further incubated with EasySep magnetic 
nanoparticles. Cells were then placed into the EasySep magnet. The two fractions 
(FDC-enriched and flow-through) were collected and lysed in Trizol, followed by RNA 
isolation and cDNA synthesis.  
 
8.10 Stimulation of peritoneal Mφs 
Three months before use 30 g of fluid thioglycollate medium (Difco) were rehydrated 
in 1 l ddH20 and autoclaved. Mice were injected i.p. with 1 ml thioglycollate 
suspension and 48h later, they were sacrificed and the peritoneum was flushed with 
cold PBS to harvest the Mφs. For in vitro stimulation peritoneal Mφs were isolated by 
peritoneal lavage and cultured over night in serum-free DMEM containing Pen/Strep. 
Then cells were washed and the adherent Mφs were stimulated with either 100 ng/ml 
LPS, 100 ng/ml LPS and 10 ng/ml IFNγ ( which was added 2h before the addition of 
LPS) or 20 ng IL-4 for 24h. Then cells were harvested and lysed in Trizol (Sigma). 
RNA and cDNA-synthesis followed and Mfge8 expression was quantified by RT-
PCR. 
 
8.11 In situ RNA Hybridization  
The Mfge8 riboprobe was obtained by transcription of pBluescript II KS+ (Stratagene) 
containing the ORF of Mfge8 using a DIG RNA Labeling Kit, Roche. ISH was 
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performed on spleen cryosections. For the fluorescent ISH, sections were prestained 
with biotinylated anti-CD68 antibody. Sections were post-fixed in 4% PFA in PBS 
followed by acetylation with 0.5% acetic anhydride in 0.1 M triethanolamine. 
Hybridization was carried out in buffer containing 50% formamide, 5x Saline Sodium 
Citrate (SSC) solution, 100 μg/ml E. coli t-RNA (Roche) and 5x Denhardt’s solution. 
For in situ RNA hybridization 200 ng/ml DIG-labeled RNA probe was added to the 
hybridization buffer and incubated at 72°C overnight. For detection either anti-DIG-
AP or anti-DIG-fluorescein antibody with a fluorescent enhancer kit (Roche) was 
used.  
 
8.12 Electron microscopy 
FDC clusters or tissue fragments from lymph nodes and spleens from BM-chimeras 
were fixed (60 min at 4°C) in a glutaraldehyde solution (2%) in 0.1 M cacodylate 
buffer (pH 7.4), washed and post-fixed for 30 min in a mixture of 1% OsO4 and 1.5% 
K4Fe(CN)6 in 0.1 M cacodylate buffer (pH 7.4), dehydrated and embedded in EPON 
812 (Fluka, Belgium). The resin specimens were trimmed and 70–90 nm sections 
were cut. Ultrathin sections were collected on copper 6200 girds and contrasted with 
uranyl acetate and lead acetate before examination with a Jeol CX 100 II 
transmission electron microscope at 80 kV. 
 
8.13 Quantitation of autoantibodies by ELISA 
To quantify serum levels of dsDNA and ANA antibodies, serum was collected from 
BM-chimeras 41 weeks post reconstitution. Titre-determination was done with the 
Anti-Nuclear Antibodies ELISA KIT and the Mouse Anti-dsDNA (IgG) Antibodies 
ELISA KIT from Alpha Diagostic according to the manufacturer´s instructions. In brief, 
appropriate serum dilutions were incubated on precoated ELISA plates. After addition 
of an HRP-conjugated anti-mouse Ig antibody, substrate was added. Enzymatic 
reaction was stopped after 15 min and absorbance was measured at 450 nm in an 
ELISA reader. Absorbance-values of the standard were plotted on a semi-log graph. 
After background-subtraction titre-concentrations of each sample was determined 
using the standard curve. 
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8.14 Prion inoculations 
Mice were infected i.p. with 100 μl of brain homogenate diluted in PBS with 5% BSA 
and containing 3-6 logLD50 units of the Rocky Mountain laboratory (RML) scrapie 
strain (passage 6, hence called RML6). For i.c. inoculations, 30 μl of inoculum with 3-
6logLD50 units were administered. Scrapie was diagnosed according to clinical 
criteria (ataxia, kyphosis, priapism and hind leg paresis). Mice were sacrificed on the 
day of onset of terminal clinical signs of scrapie. 
 
8.15 Histoblotting 
Spleen cryosections were blotted onto nitrocellulose membrane wetted in lysis buffer 
(0.5% Nonidet P-40/0.5% sodium deoxycholate/100 mM NaCi/lO mM EDTA/10 mM 
Tris-HCl, pH 7.8). For detection of PrPSc the membranes were thoroughly air dried, 
rehydrated for 1h in TBS-T and then subjected to limited proteolysis in digestion 
buffer (proteinase K at 400 μg/ml, for 18 hr at 37°C in 0.1% Brij 35/100mM NaCl/10 
mM Tris-HCl, pH 7.8). To stop the reaction the blots were rinsed three times in TBS-T 
and incubated for 30 min in TBS-T/3 mM phenylmethylsulfonyl fluoride. Finally, the 
blots were incubated in 3 M GdnSCN/10 mM Tris HCl, pH 7.8, for 10 min and rinsed 
three times in TBS-T before immunostaining. The blots were then blocked with 5% 
Topblock and incubated the primary antibody (POM1). For detection a AP-conjugated 
secondary antibody was used. 
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